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ABSTRACT 
 
Directed Evolution of Phosphotriesterase: 
 
Towards the Efficient Detoxification of Sarin and Soman.  (May 2004) 
 
Karin T. Lum, A.B., Smith College 
 
Chair of Advisory Committee: Dr. Frank M. Raushel 
 
 
 Directed evolution studies were done with PTE for the enhancement of hydrolysis of 
both sarin and soman analogs.  Particular attention was focused on the toxic SpRc and SpSc 
isomers of the soman analog, and the Sp isomer of the sarin analog.  Double substitution 
libraries yielded several mutants that had enhanced activity for the substrates.  Among them 
was the double mutant, H257Y-L303T, which displayed a 462-fold increase in activity for 
hydrolysis of the most toxic SpSc isomer of the GD analog in comparison to the wild type.  
Several other mutants such as the triple mutants H254R-H257A-L303T and H254R-H257S-
L303T had enhancements of between 150- and 200-fold, and had also displayed a different 
order of stereoselectivity relative to the wild type.  For these mutants, the order of 
preferential hydrolysis was such that the SpRc isomer was preferentially hydrolyzed first.  In 
contrast, the order of preferential hydrolysis for the wild type was that the RpRc was 
hydrolyzed first, followed by the RpSc, SpRc, and then the SpSc isomer.   
 The reversal of stereoselective preference was also seen with the double substitution 
library members for hydrolysis of the sarin analog isomers.  However, there were no 
significant improvements for sarin analog hydrolysis in these libraries.  Among the best 
mutants obtained were H254G-H257W, H254G-H257R, and H257Y, all of which had 
catalytic efficiencies on the order of 106 M-1 s-1 for hydrolysis of the Sp isomer.  
 iv
The toxicity for analogs of sarin, soman, and VX was evaluated using Hydra 
attenuata as a model organism.  The toxicity of each compound was assessed quantitatively 
by measuring the minimal effective concentration within 92 h in H. attenuata.  There was a 
positive correlation between the molecular hydrophobicity of the compound and its ability to 
cause toxicity.  Results from this study indicate the potential for application of this assay in 
the field of organophosphate nerve agent detection, as well as for the prediction of toxicity of 
structurally similar organophosphate compounds.  The minimal effective concentration for 
two of the VX analogs was 2 orders of magnitude more toxic than the analog for soman and 
four orders of magnitude more toxic than the analog for sarin. 
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CHAPTER I 
INTRODUCTION 
 
Background 
Background Information on Phosphotriesterase (PTE) 
Phosphotriesterase (PTE) is an enzyme that was found in two different soil bacteria, 
Pseudomonas diminuta MG and Flavobacterium sp. strain ATCC 27551 during the 1970’s 
(Mulbry et al., 1986).  While the Pseudomonas diminuta protein was first discovered in the 
United States, and the Flavobacterium sp. protein was found in the Philippines, cell-free 
extracts from both bacteria were capable of hydrolyzing several organophosphorus 
insecticides such as methyl parathion and paraoxon faster than base-catalyzed hydrolysis 
(Chaudry et al., 1988).  Sequence analysis via restriction digest patterns of the both genes 
revealed that the 1693 bp opd gene was virtually identical (Mulbry et al., 1986).   
The opd gene was subcloned into Escherichia coli, and the protein was over 
expressed and purified to homogeneity (Omburo et al., 1992).  It was determined that the 
protein exists as a homodimer, with each monomer weighing approximately 36 kD (Donarski 
et al., 1989).  Within each monomer is a binuclear metal center that is essential for catalysis.  
In Nature, PTE exists as a zinc metalloprotein.  However, the zinc may be replaced with 
divalent cations such as Mn2+, Co2+, Cd2+, and Ni2+ while still maintaining catalytic activity 
(Omburo et al., 1992).  Removal of the metal ions with chelators such as EDTA, and 1,10-
phenanthroline produces the apoenzyme form of the protein, which is essentially inactive 
(Omburo et al., 1992).   
 _______________________                                                   
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Titration experiments also implicated the requirement of two metals for catalytic 
activity.  The highest activity for the hydrolysis of paraoxon has been reported with the use 
of Co2+/Co2+ PTE, which has a kcat/Km of 3.8 x 107 M-1s-1 (Omburo et al., 1992).  The 
activities reported for other metal ions are lower than that of Co2+, in the following order of 
Zn2+, Mn2+, Ni2+, and Cd2+.  The kcat/Km for the Zn2+/Zn2+ PTE enzyme and the Cd2+/Cd2+ 
PTE enzyme is 3.4 x 107 M-1s-1 and 7.0 x 106 M-1s-1, respectively (Omburo et al., 1992). 
PTE catalyzes the hydrolysis of many organophosphates and their related 
phosphonates with high catalytic efficiency and broad substrate specificity (Chen-Goodspeed 
et al., 2001a).  Of particular interest are the organophosphate nerve agents, which have shown 
to be hydrolyzed, and thus detoxified, by this enzyme.  The best rates for hydrolysis have 
been shown with the insecticidal agent, paraoxon.  The PTE-catalyzed reaction occurs with a 
rate constant (kcat/Km) of 4 x 107 M-1s-1 and a turnover rate of approximately 2200 s-1 (Shim 
and Raushel, 2000).  It has been determined that the hydrolysis of phosphotriesters occurs via 
a SN2-like process, in which an activated hydroxyl group displaces the leaving group of the 
substrate resulting in an inversion of configuration at the phosphorus center (Lewis et al., 
1988).   
P
O
OO
O
NO2
H2O
-O NO2P
O
OHO
O
+
 
Scheme 1.  The hydrolysis of paraoxon results in p-nitrophenol and diethylphosphate. 
 
In terms of tertiary folding, each monomer consists of eight parallel β sheets (β/α)8, 
similar to the classic example that is seen in triose phosphate isomerase (TIM).  The TIM-
barrel fold is maintained in other amidohydrolase superfamily members such as urease, 
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adenosine deaminase, and dihydroorotase, implying a direct relationship via divergent 
evolution (Holm and Sander, 1997).  Similar to these proteins, PTE contains the (β/α8) fold 
as seen in Figure 1.1. 
As with most of the other TIM-barrel containing proteins, the active site of PTE is 
located at the C-terminal end of the β-barrel of the (β/α)8 motif (Nagano et al., 2002).  
Within the active site, there is a binuclear metal center, in which the more buried metal, 
known as the α metal, is ligated to His55, His57, and Asp301 (Figure 1.2).  The more 
solvent-exposed metal, known as the β metal, is ligated to His201, His230, and two water 
molecules.  The carboxylated K169 residue bridges the two metal ions, in addition to a 
hydroxide which is believed to be the nucleophile during the hydrolysis of the substrate 
(Benning et al., 2001).     
It has been determined that the space available within the binding pockets dictates the 
stereospecificity of the enzyme.  This is observed in previous studies in which both the 
substituent size and the binding pocket size were varied (Chen-Goodspeed et al., 2001a,b).  
The effects of substrates containing either methyl, ethyl, isopropyl, and or phenyl 
substituents at the phosphorus center were probed.  It was determined that the wild type 
protein preferentially catalyzed the hydrolysis of the Sp enantiomers over the Rp enantiomers, 
with a factor ranging from 1 for the methyl ethyl p-nitrophenyl phosphate substrate (I) to 90 
for the methyl phenyl p-nitrophenyl phosphate substrate (II) as shown in Figure 1.4 (Chen-
Goodspeed et al., 2001a).     
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Figure 1.1.  Phosphotriesterase is a homodimer protein, that contains an (β/α)8 TIM barrel 
fold (1PTA pdf file from Benning et al., 1994). 
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His 230
His 201
Lys 169
His 57
His 55Asp 301
 
 
 
 
 
 
 
 
Figure 1.2.  The zinc binuclear metal center of PTE is shown with the ligated amino acids. 
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Figure 1.3.  The structures of Sp–(I) and Rp–(I) methyl ethyl p-nitrophenyl phosphate, and the 
structures of Sp–(II) and Rp–(II) methyl phenyl p-nitrophenyl  phosphate.  
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This observation, in conjunction with structural information of PTE with a bound 
substrate analogue, has implied that the Sp enantiomer fits in a way such that the larger 
substituent is in the large subsite, and the smaller substituent is in the small subsite of the 
active site.   
 From the crystal structure of Zn2+/Zn2+ PTE, it is apparent that there are three binding 
subsites: a large pocket, a small pocket, and the leaving group subsite (Benning et al., 2001).   
As illustrated in Figure 1.3, the residues that define the small pocket are Gly60, Ile106, and 
Ser308.  Residues that line the large pocket are His254, His257, Leu271, and Met317.  In the 
leaving group pocket, there are the hydrophobic residues Trp131, Phe132, and Tyr309.   
In addition to effects from variation of substituent size, it was determined that 
modification of the small and large subsite residues also contributed to the stereoselectivity.  
The residue Gly60 was modified to an Ala, thereby decreasing the space available within the 
small subsite.  The mutation resulted in a significant decrease for the catalytic constants for 
hydrolysis of the Rp enantiomer, leading to a subsequent increase in the ratio of rates for 
hydrolysis of the Sp over the Rp-enantiomer.   
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Tyr 309
Phe 132
Trp 131
Ser 308
Gly 60
Ile 106
Leu 303
Leu 271
Met 317
His 257
His 254
large subsite small subsite
leaving group
pocket
 
 
 
 
 
 
 
 
Figure 1.4.  The residues of the large and small subsites, and the leaving group pocket within 
the active site of PTE.  The substrate modeled in the active site is the RpSc isomer of the 
soman analog, pinacolyl p-nitrophenyl methyl phosphonate.  The figure has been modified 
based upon the 3-D structural information from zinc-containing PTE (Vanhooke et al., 1996). 
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In contrast, a reduction in the physical size of the large subsite resulted in a reversal 
of the preference that was observed with the wild type protein.  As in the case with the 
H257Y mutant, a Tyr residue was used to replace His in the 257 position causing there to be 
less space available within the large subsite.  The His to Tyr mutation led to a decrease in the 
catalytic efficiency for the Sp enantiomers, and an overall preference for the Rp enantiomers.  
For the Rp enantiomer, the larger substituent is in the small subsite and the smaller 
substituent is in the large subsite.      
Similar perturbations in the large subsite were also studied by the Wild laboratory.  In 
particular, the H254R, H257L, and H254R-H257L mutants were tested with VX and soman 
analogs (Di Sioudi et al., 1999).  There was enhanced substrate specificity with each of the 
mutants for the VX analog, demeton-S.  In addition, there was a 11- and 18-fold increase in 
the catalytic efficiency for soman analog hydrolysis for the H257L and H254R-H257L, 
respectively.   Results from this study indicated that modification in the large subsite led to 
increased structure flexibility, allowing for larger substrates to fit better within the active site.   
 The importance of both large subsite residues 254 and 257 was also mentioned in a 
study comparing PTE with the OpdA protein obtained from Agrobacterium radiobacter P230 
(Yang et al., 2003).  Comparison of both proteins revealed a 90% identity at the amino acid 
level.  The active sites of both proteins were also extremely similar.  In the same study, 
directed evolution studies with the opd gene, combined with screening, resulted in the 
finding of H254R in all third generation mutants identified as having enhanced activity for a 
coumaphos substrate.  It was also noted that there is a Arg in position 254 and a Tyr at 
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position 257 for the opdA protein, instead of His that is found in both positions in PTE (Yang 
et al., 2003). 
 
PTE-catalyzed Detoxification of Nerve Agents 
The potential use of PTE for the detoxification of organophosphate nerve agents and 
pesticides appears to be promising.  In animal studies, it has been shown that mice pretreated 
with PTE before organophosphate exposure have a significant increase in resistance when 
given doses that are higher than the expected LD50 (Tuovinen et al., 1999).  In the Tuovinen 
study, the result is quite dramatic for protection against intraperitonally injected paraoxon.  
Pre-treated mice showed no sign of adverse affect up to fifty times the dose tolerated by the 
untreated mice (Tuovinen et al., 1994).   
PTE has been shown to hydrolyze the nerve agents, sarin (GB), soman (GD), and VX but the 
rate constants for the enzymatic hydrolysis of these substrates is significantly lower than 
other substrates such as paraoxon (Di Sioudi et al., 1999).  In considering the potential 
application of PTE, one must also account for the differential toxicities that each isomer of 
these agents elicits (Benschop et al., 1984).  As shown in Figure 1.5, there is one chiral center 
for both GB and VX, resulting in two isomers, and for GD there are two chiral centers and 
four isomers. 
 
 
                                                                                       
11
P
O
F
CH3OP
O
F
H3C O
P
O
F
CH3OP
O
F
H3C O P
O
F
CH3OP
O
F
H3C O
P
O
S
H3C O
N
P
O
S
CH3O
N
Sp-(III)Rp-(III)
RpRc-(IV) RpSc-(IV) SpRc-(IV) SpSc-(IV)
Rp-(V) Sp-(V)
P
O
S
H3C O
N
P
O
S
CH3O
N
Rp-(VI) Sp-(VI)  
 
 
 
 
 
 
 
Figure 1.5.  The chemical structures are shown for each of the stereoisomers of sarin (III), 
soman (IV), VX (V), and Soviet V-gas (VI).   
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As observed in previous in vitro mouse studies conducted with GB and GD, the Sp 
enantiomer of sarin is more toxic (Spruit et al., 2000).  The two Sp diastereomers of soman 
have been shown to be at least 50 times more toxic than the two Rp diastereomers (Benschop 
et al., 1984).  Inhibition rate constants of the individual isomers on AChE reveal that the Sp 
isomer of GB is approximately 4000 times more reactive than the Rp isomer (De Jong et al., 
1988).  The rate constant (M-1 min-1) for inhibition of AChE by the individual Rp and Sp 
isomer of GB is 3 x 103 and 1.4 x 107, respectively (De Jong et al., 1988).  For inhibition 
elicited by the stereoisomers of GD, the rate constant is less than 5 x 103 for both the Rp 
diastereomers, 2.8 x 108 for the SpRc, and 1.8 x 108 for the SpSc isomer (De Jong et al., 1988). 
Both the toxicity and inhibition data provide distinct results, indicating that the 
individual isomers elicit differential effects which appear to be determined more by the 
chirality at the phosphorous center than the chirality of the alkoxy center of anti-
cholinesterase inhibitor such as GD (De Jong et al., 1988). 
 
Other Organophosphate Hydrolyzing Protein and Applications 
 DFPase has also been identified as an enzyme capable of hydrolyzing nerve agents, 
specifically tabun, sarin, cyclosarin, diisopropyl fluorophosphate (DFP), and soman.  
Although it is an organophosphate hydrolyzing protein, it shares no similarity to other 
proteins such as butyrylcholinesterase, organophosphorus acid anhydrolase, and PTE.  It was 
isolated from the head ganglion of Loligo vulgaris, and exists as a monomer of 314 amino 
acids.  The protein has excellent activity against DFP, with a kcat of 526 s-1 and a kcat/Km of 
1.3 x 106 M-1 s-1 (Hartleib and Rüterjans, 2001).  However, the activity for both sarin and 
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soman are lower than PTE, and unlike PTE, DFPase is not capable of hydrolyzing the most 
toxic nerve agent, VX.  The structure of the enzyme is shown in Figure 1.6. 
The main advantage of all organophosphate hydrolyzing enzymes is their non-
corrosive nature.  Currently, the method for decontamination of chemical warfare agents 
involves the use of bleach, which is harsh, corrosive, and bad for the environment (U.S. 
Congress, 1993).  Protein is easily obtainable in substantial amounts, and is cost efficient.  
Applications of enzyme use include the use of polyurethane foams, and various types of 
sensors.   
 Polyurethane foams have been found to have a high binding affinity to nerve agents, 
and have been able to successfully shield PTE from environmental factors such as pH and 
temperature, that detrimentally affect catalytic activity (LeJeune et al., 1998).  The enzyme-
polyurethanes are readily formed within minutes, and have proven to be effective in 
decontamination exercises (LeJeune et al., 1998).  The lifetime of catalytic activity has been 
shown to be substantially increased with the use of foam.  The enzyme within the foam 
retains 100% activity for 25 days, whereas the enzyme alone rapidly decreases in catalytic 
activity just after the first day (LeJeune et al., 1998). 
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Figure 1.6.  The structure of DFPase from Loligo vulgaris, depicting a 6-fold β propeller 
motif.  The Protein Data Bank ID of this structure is 1E1A (Scharff et al., 2001). 
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Amperometric sensors have been constructed using PTE, where the enzyme is co-
immobilized with albumin on a nylon net.  Together, they are attached to a carbon paste 
electrode, and are capable of detecting organophosphate insecticides such as parathion and 
paraoxon within the nM range (Chough et al., 2002).      
History of Organophosphate Nerve Agents 
The German pharmaceutical company, Bayer, developed the first organophosphate 
insecticides (U.S. Department of Defense, 1998).  Upon the discovery of their anti-
acetylcholine esterase (AChE) activity, the newly developed insecticides were used as nerve 
agents.  Other compounds were synthesized within a period of 30 years.  Among them were 
the organophosphate nerve agents tabun (GA), sarin (GB), cyclosarin (GF), soman (GD), and 
VX (U.S. Department of Defense, 1998).  As seen in scheme 2, GA has a cyanide leaving 
group.  The three remaining G agents, GB, GF, and GD, each have  
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VXtabun (GA) sarin (GB) soman (GD)
P
O
F
O
cyclosarin (GF)  
 
Scheme 2. The chemical structures of the 5 most common organophosphate nerve agents; 
tabun (GA), sarin (GB), cyclosarin (GF), and VX. 
 
a fluorine leaving group, and VX has a thiolate leaving group.  The G agents are considerably 
volatile, implying that toxicity occurs readily via inhalation exposure routes.  Toxicity 
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resulting from the V agents is far greater in terms of dose required for lethality.  However, V 
agents such as VX are not volatile, but are far more persistent.  Toxicity occurs primarily via 
a percutaneous route (i.e. droplets on skin) (Munro, 1994).  In general, the 
organophosphate nerve agents share the characteristics of being highly toxic and stable 
(Munro, 1994).    
  
Organophosphate Compounds and Toxicity 
The organophosphates were first recognized as a distinct class of compounds in 1854, 
but the toxicity associated with this class of compounds was not discovered until the 1930’s 
(Moseley and Snead, 1953).  The first organophosphate insecticide synthesized was 
tetraethyl pyrophosphate (TEPP) (Minton and Murray, 1988).  As of the late 1980’s, there 
have been over 100,000 compounds screened for insecticidal use, and over a hundred are 
available for commercial use (Minton and Murray, 1988).  The effect of organophosphate 
compounds on the environment has been, and continues to be, very critically analyzed by the 
U.S. Environmental Protection Agency (EPA).  Although the usage of organophosphate 
pesticides has declined approximately 30% from 1980 to 1999, this particular class of 
compounds still accounted for 72% of the 126 million pounds of active ingredients within 
pesticides for 1999 (Donaldson et al., 2002).  Malathion, chlorpyrifos, diazinon, and methyl 
parathion are among the top ten active ingredients used annually by the pesticide industry.  
The structures are depicted in Scheme 3.  Each of these compounds has been shown to cause 
toxicity, and have resulted in a number of exposure-toxicity case studies (Donaldson et al., 
2002). 
 
                                                                                       
17
O P
S
S
malathion
O
O
O
O
O
N
Cl
Cl
Cl
O
P
S
O
O
chlorpyrifos diazinon methyl parathion
N
NO
P
S
O
O
P
S
OO
O
NO2
 
 
Scheme 3.  The chemical structures are shown for the pesticidal agents, malathion, 
chlorpyrifos, diazinon, and methyl parathion. 
 
As a class, the organophosphates are structurally characterized as compounds 
containing a pentavalent phosphorus.  Typically, one substituent is double bond bonded to 
oxygen, sometimes a sulfur is used instead, and the three remaining substituents are varied.  
This variation leads to the broad range of structures within this class, and the complexity in 
determining their differential targets.  Direct targets of organophosphates include 
acetylcholine esterase (AChE), the muscarinic acetylcholine receptor (mAChR) and the 
nicotinic acetylcholine receptor (nAChR) (Marrs et al., 1996).  Other enzymes that have 
detoxifying capabilities are phosphotriesterase (PTE), paraoxonase (PON), as well as squid 
enzyme and organophosphate acid anhydrolases (Tuovinen et al., 1994)(Veronesi et al., 
1997)(Hartleib and Rüterjans, 2001)(Cheng et al., 1999). 
The mechanism of toxicity of these nerve agents is similar to that of organophosphate 
insecticides such as paraoxon and chlorpyrifos, and many of the details of organophosphate 
toxicity have been determined by using paraoxon and chlorpyrifos as model substrates 
because they are considerably less dangerous (Mileson et al., 1998).  The toxicity occurs 
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primarily by inhalation and percutaneous absorption, as seen with the toxicity data reported 
in Table 1.  Exposure through these routes results in the inhibition of AChE and affects the 
AChR and ionic channels (i.e. a more direct route than AChE) thereby causing cholinergic 
excess (Tuovinenen et al., 1994).  While there has been considerable attention directed 
towards dealing with the toxicity of these compounds (Mileson, 1998), other complexities 
involving the mechanism of action have yet to be elucidated.  One such complexity is the 
occurrence of compartmentalization of soman into depots within the skin, muscles, and 
lungs, which has been observed in some studies (Kadar et al., 1985).  Although a small 
fraction is contained in the depot, only 1-3% of the dose administered elicits the toxic effects, 
so that the quantity within the depot may prove to be significant in determining toxicity 
(Bajgar, 1996).  
For the testing of nerve agents in living systems, there has been significant 
toxicological data compiled on the effects of the nerve agents in their racemic mixture.  
However, several studies indicate that there are substantial differences in the toxicological 
properties between different stereoisomers of the same compound due to stereospecific 
interactions involved in AChE-OP binding (Ordentlich et al., 1999) (Benschop et al., 1984).  
In such studies, it has been determined that for soman, the two Rp enantiomers are relatively 
non-toxic, whereas the SpSc enantiomer is extremely toxic and the SpRc contributes 
somewhat to this toxicity (Benschop et al., 1984).  The structures of the individual isomers 
are shown in Figure 1.5.  
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Table 1.1.  The toxicity of the most common organophosphate nerve agents (USAMRICD, 
1995).  Vapor toxicity is expressed as LCt50, ICt50, and MCt50 and reported in terms of mg 
min m3, whereas the LD50 represents toxicity via percutaeous absorption, and it is reported in 
terms of mg quantity.   The terms, LCt50, ICt50, and MCt50 , are lethal concentration, 
incapacitating concentration, and miosis concentration, respectively, for 50 percent of the 
population.  The LD50 represents the dose that causes lethality to 50 percent of the 
population. 
 
 
 
 
 
 
Agent LCt50 ICt50 MCt50 LD50 
GA 400 300 2-3 1000 
GB 100 75 3 1700 
GD 70 n/a <1 50 
GF n/a n/a <1 30 
VX 50 35 0.04 10 
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Athough all avenues of organophosphate toxicity have yet to be fully elucidated, it is 
clear that cholinergic effects are primary and there is inhibition of AChE (e.g. anti-AChE).  
In terms of anti-AChE activity, the reactivity of each organophosphate is derived from the 
intrinsic electrophilicity of the phosphorus, which is determined by how electron 
withdrawing the leaving group is, in addition to how well the substituents fit into the target 
active site (Mileson et al., 1998).  Secondary effects of organophosphate toxicity are 
mediated by hormones, and symptoms such as hyperglycemia, hyperlipidemia (Somani, 
1992). 
   
AChE: The Primary Target of Organophosphate Nerve Agents 
Transmission at a chemical synapse is initiated by an action potential.  As an action 
potential arrives at the presynaptic membrane, there is depolarization of the synaptic 
terminus, which triggers the opening of voltage-gated Ca2+ channels.  The subsequent influx 
of extracellular Ca2+ into the presynaptic terminals results in the exocytosis of synaptic 
vesicles containing AChE (Dan and Poo, 1992).  As illustrated in Figure 1.7, the 
acetylcholine (ACh) packets are released into the synaptic cleft where they may bind to 
receptors on the postsynaptic membrane.  The binding of ACh at the receptor causes a 
change in ion permeability, leading to the subsequent change in membrane potential of the 
postsynaptic membrane (Matthews, 1991). 
AChE is a serine esterase that resides at the sites of mAChR and nAChR (Somani, 
1992).  It catalyzes the degradation of ACh into acetate and choline, which ends the nerve 
transmission.  Within the active site of AChE, there is a catalytic triad similar to that of 
serine proteases, which is comprised of Ser200, His440, and Glu237.  Without the presence 
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of AChE inhibitors, this enzyme maintains a kcat on the order of 105 min-1, which is 
considered to be a turnover rate close to perfection (Froede and Wilson, 1984).  However, if 
organophosphate nerve agents are present, there is phosphorylation at the catalytic serine, 
resulting in dead enzyme (Marrs et al., 1996).  In addition, the inhibition of AChE activity 
results in an increased concentration of ACh in the synapses and neuromuscular junctions, 
leading to the over stimulation of the cholinergic receptors, nAChR and mAChR (Veronesi et 
al., 1997).   As overstimulation occurs, symptoms that typically manifest are miosis, 
bronchial constriction, sweating, and increased secretion within the trachial-bronchial tract.  
Other symptoms such as tremors, seizures, and death may occur if the administered dose is 
high enough (Hartmann, 2002).  
 
nAChR and mAChR: The Secondary Targets of Nerve Agents 
The secondary effect of AChE inhibition is the sustained activation of the cholinergic 
receptors.  Although this is considered a secondary effect, direct binding of ACh, as well as 
organophosphates, has been well documented (Veronesi et al., 1997) (Katz et al., 1997).  In a 
study by Katz et al., the nAChR agonist carbamoylcholine and the non-competitive allosteric 
antagonist [3H] thienyl-cyclohexyl-piperidine (TCP) were used to determine the binding of 
ACh and the organophosphates, chlorpyrifos and parathion (Katz et al., 1997).  Because the 
organophosphates were able to bind while ACh (active site) and TCP (allosteric site) were 
bound, it was determined that the organophosphates used were bound to a separate site, 
distinguishable from both the active and labeled allosteric sites.   
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Figure 1.7.  A signal travels down the axon to initiate the release of ACh from synaptic 
vesicles into the neuromuscular junction. 
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 The details of the binding states, such as conformation and ligand affinity, were also 
examined by several related experiments.  There were three different conformations of 
nAChR described; a resting state with little affinity for ACh, a desensitized state 
characterized by very high affinity for ACh or carbamylcholine while remaining inactivated, 
and an active state marked by very high affinity.  A desensitized state could result from two 
possible outcomes.  One of which could be a general increase in ACh levels leading to 
subsequent activation of nAChR, triggering conformational changes leading to the state and 
possible “receptor plasticity,” whereby repeated OP exposure resulted in down regulation of 
both types of cholinergic receptors.  The other possibility entails the activation of mAChR in 
the heart and blood vessels, leading to symptoms such as bradycardia, hypertension, and 
asphyxiation (Katz et al., 1997).   
Similar experiments were done using mAChR.  The main differences between the 
two receptors are location and structure.  The nAChRs which contain 5 subunits (), 
are located in the autonomic nervous system, neuromuscular junctions and the brain.  The 
binding of ACh occurs at the  subunit (Somani, 1992).  Each mAChR consists of 7 
transmembrane domains, and they are G-protein-coupled receptors found within the 
parasympathetic nervous system (Huff and Abou-Donia., 1995). 
The five subtypes of mAChR are classified according to which G protein family they 
are coupled to.  When activiated by ACh, M1, M3, and M5 stimulate phosphatidylinositol 
phosphate hydrolysis through the Gp family whereas M2 and M4 trigger the inhibition of 
adenylate cyclase through the Gi family when activiated (Huff and Abou-Donia, 1995).   
In a study by Silveira et al., [3H]cis-methyl dioxolane was used as an agonist 
competing against the organophosphate nerve agents, GA, GB, GD, and VX to determine the 
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location of organophosphate binding on M2AChRs (Silveira et al., 1990).  It was determined 
that both the nerve agents and ACh bind to the active site.  Other organophosphates, such as 
chlorpyrifos were found to be less competitive, and less toxic.  Thus, a correlation between 
competitive inhibition and toxicity was established for the target mAChR (Silveira et al., 
1990). 
 
Current Treatment of Organophosphate-induced Toxicity 
The methods available for treating toxicity induced by organophosphate compounds 
are prophylaxis, antidote, regenerators, and anticonvulsants.  Prophylaxis involves the 
reversible binding of a carbamate, which acts as a competitive AChE inhibitor with the nerve 
agent.  Toxicity is prevented by constant release of active enzyme from binding with 
carbamates such as the stigamines.   However, a limitation associated with prophylaxis 
agents is timing.  They must be administered before exposure in order to be effective.  An 
example of a carbamate prophylaxis agent is pyridostigamine, as shown in Figure 1.8.   
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Figure 1.8.  The structures of a prophylaxis agent (i.e. pyridostigamine), an antidote (i.e. 
atropine), and a regenerator (i.e. pralidoxime).   
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In the event that exposure has occurred, antidotes, regenerators, or anticonvulsants 
may be used.  An antidote such as atropine is used as a cholinergic antagonist, to titrate 
against symptoms of cholinergic excess.  Regenerators, such as oximes (i.e. pralidoxime) 
block the binding of organophosphates to AChE, and reactivate the enzyme of nerve endings 
(Sidell, 1994).  These, however, must be administered early after exposure due to a post 
inhibitory reaction known as aging.  After the nerve agent has phosphorylated the active site 
serine, the compound is still susceptible to dealkylation of its branched alkyl groups, 
otherwise known as aging, which leads to irreversible enzyme inhibition (Millard et al., 
1999).   
Anticonvulsants act to counter the central nervous system effects, so that cardio-
respiratory function can be normalized.  The anticonvulsant agent is most effective if it can 
penetrate the blood-brain barrier to prevent resulting brain damage (Mileson, et al., 1998).   
 
Conclusions 
The potential use for phosphotriesterase as an agent to combat chemical warfare 
agents has been demonstrated in a number of studies (Tuovinen et al., 1994)(Tuovinen et al., 
1999).  Phosphotriesterase (PTE) is the only protein that has been found thus far to 
hydrolyze, and thereby detoxify, both the G- and V-series of nerve agents (Raushel, 2002).  
Data from both in vitro and in vivo experiments indicate the promise that this protein has for 
use in bio-remediation types of applications.  However, a formidable obstacle impeding the 
advancement of its use in such applications is the characteristic stereoselectivity that the 
enzyme exhibits, as well as the rates of hydrolysis.  From previous studies, it is clear that the 
wild-type enzyme naturally prefers the isomer that corresponds to the least toxic isomer of 
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the nerve agent (Li et al., 2001).  This is true in the case of both the sarin and soman analogs 
that have been used as substrates for PTE.     
There have been several strategies used to modify the stereoselectivity of the enzyme, 
as well as enhance the rates of hydrolysis.  Among them, the methodology of directed 
evolution and random mutagenesis has been employed targeting residues within the active 
site of PTE.  This thesis describes efforts towards the goal of improving phosphotriesterase 
for enhanced hydrolysis against the individual toxic isomer of sarin and soman. 
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CHAPTER II 
STEREOSELECTIVE DETOXIFICATION OF SARIN AND 
SOMAN ANALOGS 
 
Introduction  
 Activated organophosphate triesters and organophosphonate diesters are very toxic 
materials because of their inherent ability to inhibit the enzyme acetylcholinesterase (AChE).  
This property has been exploited over the last half century through the development of 
numerous commercial insecticides for agricultural and household uses.  For example, in the 
USA today, there are approximately 40 organophosphate insecticides registered for use by 
the Environmental Protection Agency.  Each year approximately 100 million pounds of 
insecticides, including acephate, malathion, and chlorpyrifos are applied to the environment 
for the control of a variety of insects and other pests (Aspelin and Grube, 1999).  The 
organophosphate insecticides inactivate AChE through the irreversible phosphorylation of an 
active site serine residue.  The persistence of organophosphate insecticides in the soil is 
significantly diminished through microbial degradation.  One of the primary bacterial 
detoxification mechanisms for organophosphate esters is enzymatic hydrolysis.  
  The phophotriesterase (PTE) from Pseudomonas diminuta is the best-characterized 
enzyme for the hydrolytic detoxification of organophosphate nerve agents (Raushel and 
Holden, 2000).  This enzyme is a zinc metalloprotein, which catalyzes the hydrolysis of a 
wide variety of organophosphates and related phosphonates with a high catalytic turnover 
and broad substrate specificity (Omburo et al., 1992).  For example, the kcat and kcat/Km 
values for the insecticide paraoxon are approximately 104 s-1 and 108  M-1s-1, respectively 
(Omburo et al, 1993).  The hydrolysis of paraoxon is illustrated in Scheme 1.   
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Scheme 1.  The hydrolysis of paraoxon results in para-nitrophenol and diethyl phosphoric 
acid. 
 
The x-ray crystal structure of PTE, determined by the Holden laboratory, has shown that the 
protein folds in a ‘TIM-barrel’ motif that is embedded with a binuclear zinc center at the 
active site (Benning et al., 1995)(Vanhooke et al., 1996).  The zinc metallo-center of PTE is 
homologous to the binuclear Ni2+-center found in urease (Jabri et al., 1995).  These enzymes 
are members of the amidohydrolase superfamily (Holm and Sander., 1997).   
It has previously been demonstrated that the bacterial PTE will hydrolyze, and thus 
detoxify, the military organophosphate nerve agents sarin and soman, although the turnover 
numbers for these compounds do not rival the rate constants for the enzymatic hydrolysis of 
insecticides such as paraoxon (Dumas et al., 1989)(Di Sioudi et al., 1999).   
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Scheme 2.  The chemical structures of the individual stereoisomers of the nerve agents, sarin 
(I) and soman (II). 
 
Nevertheless, the catalytic properties of the wild type PTE make it the leading candidate for 
the enzymatic detoxification of organophosphate nerve agents under a variety of field 
conditions.  However, of particular concern is the differential toxicity for the stereoisomers 
of the nerve agents, sarin and soman.  Sarin has a single chiral center at phosphorus while 
soman possesses an additional center of asymmetry within the pinacolyl substituent.  The 
structures of these stereoisomers are illustrated in Scheme 4.  It has been determined that the 
Sp-enantiomer of sarin inactivates AChE approximately 104 times faster than the Rp-
enantiomer (Benschop and De Jong, 1988).  For soman, the two Sp-diastereomers inactivate 
AChE approximately 105 times faster than the two Rp-diastereomers (Benschop et al., 1984).   
 The wild type PTE is moderately stereoselective for the hydrolysis of chiral 
organophosphate triesters.  All possible combinations of the substituents methyl, ethyl, 
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isopropyl, and phenyl have been synthesized and characterized as substrates for PTE using 
the template depicted in Scheme 3 (Hong and Raushel, 1999). 
 
P
O
O
OOX
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Scheme 3.  The general skeleton of phosphate substrates for PTE, in which X and Y represent 
different alkyl groups. 
 
In every case the preferred stereoisomer is the one where the substituent Y is bulkier than the 
substituent X.  The ratios of the experimental kcat/Km values for the Sp- and Rp-enantiomers in 
this series of stereoisomers ranged from 1 to 90 (Hong and Raushel, 1999).  These results 
have been shown to be consistent with the physical dimensions of the subsites within the 
active site of PTE. 
 In this chapter, the stereoselective properties of the wild type PTE toward chiral 
analogs of sarin and soman were examined.  Since the individual stereoisomers for these 
nerve agents were not readily available, novel chemo-enzymatic syntheses of chiral analogs, 
where the leaving group fluoride has been replaced with p-nitrophenol, were developed by 
Dr. Wen-Shan Li.  This substitution provides for a convenient optical signal of the cleavage 
event.  For the sarin analog the relative rates of hydrolysis for the two enantiomers varied by 
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an order of magnitude when the wild type PTE was used as a catalyst.  With the soman 
analog, the relative rates of hydrolysis differed by nearly four orders of magnitude.  A small 
number of mutations within the active site of PTE were able to reverse the stereoselectivity 
exhibited by the wild type enzyme. 
     
Materials and Methods 
 
Materials 
Restriction enzymes and T4 DNA ligase were obtained from Promega or New 
England Biolabs.  Wizard Miniprep DNA Purification System was purchased from Promega.  
Gene Clean DNA purification kit was purchased from Bio 101.  Oligonucleotide synthesis 
and DNA sequencing reactions were conducted by the Gene Technology Laboratory of 
Texas A&M University.  All of the substrates used in the following experiments, with the 
exception of paraoxon, were synthesized by Wen-Shan Li (Li et al., 2001).  The chemical 
structures of the individual stereoisomers of the sarin analog (III) and the soman analog (IV) 
are shown in Scheme 4. 
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Scheme 4.  The structures of the individual stereoisomers are shown for the GB analog (III) 
and GD analog (IV).   
 
Site Directed Mutagenesis 
Changes to the amino acid sequence of the phosphotriesterase enzyme were initiated by 
cassette mutagenesis of the opd gene within the plasmid pJW01 (Chen-Goodspeed et al., 
2001a,b).  Unique restriction sites on either side of the codon to be mutated were identified 
and the targeted site was excised with the appropriate enzymes. The digested fragment was 
purified by agarose gel electrophoresis.  The two mutagenic primers were annealed by 
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incubating 20 µL of 1-2 µM of each oligonucleotide with 2 µL of T4 DNA ligase buffer at 72 
°C for five minutes, and then incubated at 25 °C for one hour.  The annealed oligonucleotides 
and restricted pJW01 plasmid were ligated with T4 DNA ligase at 16 °C overnight and then 
transformed into E. coli BL-21 cells.  The mutated plasmids were sequenced to ensure that 
no other alterations were introduced during the mutagenic protocols.  
 
Purification of Enzymes  
The mutants and the wild type PTE were expressed in E. coli BL-21 cells as 
previously described (Kuo and Raushel, 1994).  PTE and the mutant enzymes were purified 
according to the protocol of Omburo et al. (Omburo et al., 1992).  SDS-PAGE indicated that 
the purified mutants were the same size as the wild type PTE and were at least 95% pure.  
Apoenzyme was prepared according to an established procedure and then reconstituted with 
5 equivalents of CoCl2 (Omburo et al., 1992). 
  
Kinetic Measurements and Data Analysis 
The enzymatic hydrolysis of paraoxon, and the sarin (isopropyl p-nitrophenyl methyl 
phosphonate) and soman (p-nitrophenyl pinacolyl methyl phosphonate) analogs, were 
measured by monitoring the formation of p-nitrophenol at 400 nm (ε = 17,000 M-1 cm-1) and 
25 º C using a Gilford Model 260 spectrophotometer.  The reactions were conducted in 50 
mM CHES buffer, pH 9.0, for paraoxon and the sarin analogs, while 10% methanol was 
added to improve the solubility of the soman analogs.  The kinetic constants were obtained 
by fitting the data to Equation 2.1, in which v is the initial velocity, Vm is the maximal 
velocity, A is the concentration of substrate, and Km is the Michaelis constant.   
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v = VmA / (Km+A)                                 (2.1) 
 
Substrate Specificity 
The substrate specificity for the racemic sarin (III) and soman (IV) analogs was 
conducted at a total concentration of 35 µM in 50 mM CHES, pH 9.0 at 25 °C.  The addition 
of potassium hydroxide was used to confirm the total concentration of the substrate analog.  
The hydrolysis of substrate was monitored spectrophotometrically by the appearance of p-
nitrophenol at 400 nm.  The temperature was kept constant by the use of a circulating water 
bath.   
The PTE mutants, G60A and I106A-F132A-H257Y were used in the stereoselectivity 
experiments.  The mutant G60A was the first enzyme added, and allowed to hydrolyze half 
of the total substrate within 15 minutes, as determined spectrophotmetrically.  After half of 
the substrate was hydrolyzed, the second enzyme, I106A-F132A-H257Y, was added and 
allowed to hydrolyze the remaining substrate.  The entire reaction was over in 30 minutes.  
The reaction was also done with the enzymes in reverse order such that I106A-F132A-
H257Y was added first, and then G60A was added second.     
 
Results 
Selection of G60A and I106A-F132A-H257Y and Kinetic Analysis of the Chiral Sarin 
Analogs 
A library of active site mutants of PTE was surveyed in order to identify enzymes that 
were more stereoselective for the Rp-enantiomer than the wild-type enzyme.  This same 
library was also probed for mutant enzymes that would prefer the Sp-enantiomer relative to 
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the Rp-enantiomer.  The two mutants, G60A and I106A-F132A-H257Y, were selected for 
these experiments on the basis of previous results using similar compounds as substrates.   
Chen-Goodspeed et al. determined that G60A shared the same order or 
stereoselectivity as wild type, and had higher rates for almost all of the substrates tested.  In 
every case, the mutant G60A preferred the Sp isomer over the Rp isomer (Chen-Goodspeed et 
al., 2001a).   The preference varied from a kcat/Km ratio of 12:1 for Sp:Rp methyl ethyl p-
nitrophenyl phosphate to 15,000:1 for Sp:Rp phenyl isopropyl p-nitrophenyl phosphate.  As a 
note, the Sp isomer of the phosphate substrates described in Chen-Goodspeed et al. 
corresponds to the Rp isomer of the phosphonates described in this study.   
  In contrast, the stereoselectivity of I106A-F132A-H257Y is reversed relative to the 
wild type PTE as described by another investigation done by Chen-Goodspeed et al. (Chen-
Goodspeed et al., 2001b).  In general, the triple mutant had a higher catalytic efficiency for 
the Rp isomer than for the Sp isomer of the chiral substrates tested.  However, the ratio of 
preference was more modest than those described for G60A, with the highest kcat/Km ratio of 
hydrolysis of 10:1 reported for Rp:Sp phenyl methyl p-nitrophenyl phosphate.  The I106A-
F132A-H257Y mutant was found to have an enhanced stereoselectivity for the Sp isomer of 
the sarin analog while the mutant G60A possessed a preference for the Rp isomer.   
 The differing chiral preferences for these two mutants are graphically shown in 
Figures 2.1 and 2.2.  In this experiment, G60A was able to hydrolyze only one stereoisomer 
at a significant rate of the racemic mixture while I106A-F132A-H257Y was able to 
hydrolyze the remaining stereoisomer (Figure 2.1).  This discovery permitted the utilization 
of these two isomers in the kinetic resolution of either stereoisomer from the racemic 
mixture.  When the G60A mutant was used as the hydrolytic catalyst, the Sp isomer was 
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isolated in high yield with a very low contamination by the Rp isomer.  The Rp isomer was 
isolated in high yield and excellent enantiomeric excess using the mutant I106A-F132A-
H257Y (Figure 2.2).  However, the I106A-F132A-H257Y mutant exhibits less 
stereoslectivity than the G60A mutant, as seen when both Figures 2.1 and 2.2 are compared. 
The purified enantiomers of the sarin analogs, Sp and Rp, in addition to the racemic 
mixture, were tested as substrates for the wild-type enzyme and the two mutant enzymes, 
G60A and I106A-F132A-H257Y.  For the wild-type enzyme the kcat for the Rp isomer is 
approximately 9 times faster than the Sp isomer, as graphically depicted in Figure 2.3.  The 
kcat/Km is 20 times more favorable in the direction of Rp to Sp isomer, as shown in Figure 2.4.  
For the mutant G60A, the chiral preference for the Rp isomer of the sarin analog is enhanced 
relative to the wild-type enzyme.  Thus, the ratios of kcat and kcat/Km for G60A are 50- and 
140-fold more favorable, respectively, for the Rp stereoisomer.  In contrast, the kcat for the 
triple mutant is 10 times greater for the Sp isomer than the Rp isomer while kcat/Km is 30-fold 
higher for the same isomer.  The kinetic constants are presented in Table 2.1. 
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Figure 2.1.  Time course for the hydrolysis of the racemic sarin analog (III) using the mutant 
forms of PTE.  The total concentration of the sarin analog (36 µM) was determined by the 
addition of KOH.  The PTE mutant G60A was added at time zero to hydrolyze the Rp 
enantiomer to completion.  After 15 min., the I106A-F132A-H257Y mutant form of PTE was 
added to hydrolyze the Sp enantiomer. 
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Figure 2.2.  Time course for the hydrolysis of the racemic sarin analog (III) using the mutant 
forms of PTE.  The total concentration of the sarin analog (36 µM) was determined by the 
addition of KOH.  The PTE mutant I106A-F1332A-H257Y was added at time zero to 
hydrolyze the Sp enantiomer to completion.  After 15 min., the G60A mutant form of PTE 
was added to hydrolyze the Rp enantiomer. 
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Figure 2.3.  The turnover rate for racemic GB analog (III), Rp-isomer, and Sp-isomer 
hydrolysis for wild type protein, and the mutants, G60A and I106A-F132A-H257Y.  
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Figure 2.4.  The value of kcat/Km of racemic GB analog (III), Rp-isomer, and Sp-isomer 
hydrolysis for wild type protein, and the mutants, G60A and I106A-F132A-H257Y.
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Preparation and Kinetic Analysis of the Chiral Soman Analogs 
Two sets of diastereomers were constructed and obtained from Dr. Wen-Shan Li (Li et 
al., 2001).  They were of a single configuration at the chiral carbon center, but racemic at the 
phosphorus center RpRc/SpRc and RpSc/SpSc.  For the fully racemic mixture, the wild-type PTE 
hydrolyzed one of the stereoisomers at a significantly faster rate than the others (Figure 2.5).  By 
analogy with the known stereoselectivity exhibited by the wild-type enzyme for the sarin analogs 
and other phosphotriester substrates, the more rapidly hydrolyzed stereoisomer within each pair 
of diastereomers was concluded to be of the Rp configuration (Hong and Raushel, 1999).  This 
conclusion was supported by the preference for the same isomer when the mutant G60A was 
tested with these two pairs of diastereomers. 
The differential rates of hydrolysis exhibited by G60A and I106A-F132A-H257Y for the 
two stereoisomers contained within the SpRc/RpRc mixture of diastereomers are graphically 
presented in Figures 2.6 and 2.7, and the same is shown for the differential rates of hydrolysis 
within the SpSc/RpSc mixture of diastereomers in Figures 2.8 and 2.9.  It is assumed in both cases 
that G60A is preferentially hydrolyzing the Rp isomers while I106A-F132A-H257Y is 
preferentially hydrolyzing the Sp isomers.  These contrasting stereoselectivities made it 
technically feasible to use these two mutants as catalysts for the kinetic resolution of the two 
pairs of diastereomers into the four individual stereoisomers. 
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Figure 2.5.  The preferential hydrolysis of one isomer within the racemic soman mixture (IV) 
containing 4 isomers, as exhibited by the wild type PTE.  The total concentration of the soman 
analog was 45 µM, as determined by the addition of KOH. 
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Figure 2.6.  Time course for the hydrolysis of the diastereomeric mixture of the soman analog 
SpRc–(IV) and RpRc–(IV) using G60A as the first enzyme.  The total concentration of the soman 
analog (35 µM) was determined by the addition of KOH.  The PTE mutant G60A was added at 
time zero to hydrolyze the RpRc enantiomer.  After 15 min., the I106A-F132A-H257Y mutant 
form of PTE was added to hydrolyze the SpRc enantiomer. 
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Figure 2.7.  Time course for the hydrolysis of the diastereomeric mixture of the soman analog 
SpRc–(IV) and RpRc–(IV) using I106A-F132A-H257Y as the first enzyme.  The total 
concentration of the soman analog (35 µM) was determined by the addition of KOH.  The PTE 
mutant I106A-F132A-H257Y was added at time zero to hydrolyze the SpRc enantiomer.  After 
15 min., the G60A mutant form of PTE was added to hydrolyze the RpRc enantiomer. 
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Figure 2.8.  Time course for the hydrolysis of the diastereomeric mixture of the soman analog 
SpSc–(IV) and RpSc–(IV) using G60A as the first enzyme.  The total concentration of the soman 
analog (35 µM) was determined by the addition of KOH.  The PTE mutant G60A was added at 
time zero to hydrolyze the RpSc enantiomer.  After 15 min., the I106A-F132A-H257Y mutant 
form of PTE was added to hydrolyze the SpSc enantiomer. 
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Figure 2.9.  Time course for the hydrolysis of the diastereomeric mixture of the soman analog 
SpSc–(IV) and RpSc–(IV) using I106A-F132A-H257Y as the first enzyme.  The total 
concentration of the soman analog (35 µM) was determined by the addition of KOH.  The PTE 
mutant I106A-F132A-H257Y was added at time zero to hydrolyze the SpSc enantiomer.  After 15 
min., the G60A mutant form of PTE was added to hydrolyze the RpSc enantiomer. 
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Stereoselectivity of Wild Type PTE, G60A, and I106A-F132A-H257Y for the Soman Analog 
The four soman analog stereoisomers were characterized as substrates for the wild-type 
PTE and the two mutant enzymes, G60A and I106A-F132A-H257Y.  The kcat for each individual 
stereoisomer of the GD analog is graphically represented on a log scale in Figure 2.10, while the 
kcat/Km for each steroisomer of the GD analog is shown in Figure 2.11.  For the wild-type 
enzyme the catalytic selectivity as measure by kcat/Km is RpRc : RpSc: SpRc : SpSc of 
10,000:750:23:1.  The same relative order of isomeric preferences was found for G60A as in the 
wild type.   With the G60A, the relative rates were greater than wild type and were determined to 
be 21,000:8000:1:1.  In contrast, the triple mutant preferred the isomers in the following order; 
Sp Rc, Sp Sc, Rp Rc, and then Rp Sc.  The stereoselectivity was determined to be reversed with the 
triple mutant.  The kcat/Km ratio of rates for hydrolysis was also substantially smaller, and was 
reported as 5:1:164:21 for the corresponding isomers.  The kinetic parameters are listed in Table 
2.1. 
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Figure 2.10.  The turnover rate of the individual stereoisomers of the GD analog (IV) for wild 
type protein, and the mutants, G60A and I106A-F132A-H257Y, as expressed in the log plot of 
the kcat.  
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Figure 2.11.  The catalytic efficiency of the individual stereoisomers of the GD analog (IV) for 
wild type protein, and the mutants, G60A and I106A-F132A-H257Y. 
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Discussion 
Enzymatic Hydrolysis of Sarin Analogs 
The wild type PTE and the selected mutants were able to catalyze the hydrolysis 
of both stereoisomers of the sarin analog (III).  For the Rp-isomer, the kcat and kcat/Km 
with the wild type enzyme was 2600 s-1 and 8.2 x 106 M-1 s-1, respectively.  The 
magnitude of these values was approximately one third the size of the kinetic constants 
obtained for the insecticide paraoxon.  Thus, a substantial fraction of the inherent 
catalytic power within the native PTE was available for the hydrolysis of the Rp-isomer 
of the sarin analog.  For the Sp-enantiomer of the sarin analog, the values of kcat and 
kcat/Km were approximately an order of magnitude smaller.  The stereoselectivity towards 
the Rp-enantiomer of the sarin analog was consistent with the previously determined 
substrate specificity of PTE using a small library of organophosphate triesters (Hong and 
Raushel, 1999).  The catalytic preference for the hydrolysis of the sarin analog Rp over Sp 
can also be rationalized structurally on the basis of the optimized size of the subsites for 
the binding of the i-propyl substituent relative to that for the methyl substituent of the two 
enantiomers (Benning et al., 2000).    
The wild type PTE was able to hydrolyze the analog for the most toxic 
stereoisomer of the nerve agent sarin.  However, the rate of hydrolysis of this substrate 
was significantly slower than the turnover rate with the less toxic Rp-enantiomer of the 
sarin analog.  If PTE is going to achieve its full potential as an agent for the catalytic 
destruction of toxic nerve agents, then derivatives of this protein with altered kinetic 
properties must be constructed and more fully characterized.  The catalytic properties of 
the triple mutant of PTE, I106A-F132A-H257Y, effectively demonstrated that structural 
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variants of PTE can be readily constructed with significant enhancements to both kcat and 
kcat/Km for the initially slower Sp-isomer of the sarin analog.  This objective was met 
through a subtle alteration of the two binding subsites within the active site of PTE that 
dictate the catalytic and substrate specificity of this enzyme.   
Prior x-ray crystallographic analysis of PTE in the presence of a bound inhibitor 
by the Holden laboratory has localized those residues that dictate the structural 
dimensions of these binding subsites (Benning et al., 2000).  In the example presented 
here, the small subsite was slightly enlarged through the mutation of Ile106 and Phe132 
to alanine residues while the large subsite was diminished in size by the conversion of 
His257 to a phenylalanine.  These three changed enhanced the turnover rate of the 
initially slower Sp-isomer by approximately one order of magnitude and reduced the rate 
of turnover of the initially faster Rp-isomer by the same amount.  The location of the 
residues previously mentioned is shown in a diagram of the active site in Figure 2.12.  
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Figure 2.12.  The active site residues and ligand binding residues of PTE.  Both residues 
Gly 60 and Ile 106 are located within the small subsite, while the residue His 257 is 
located within the large subsite. 
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Enzymatic Hydrolysis of Soman Analogs 
All four analogs of the soman stereoisomers were substrates for the wild type 
PTE.  However, there was a rather large variance in the rate of substrate turnover that was 
very much dependent on the specific stereochemical configuration around the phosphorus 
center and the chiral pinacoyl substituent.  The extreme values of kcat differed by a factor 
of approximately 1000 while kcat/Km for the RpRc-isomer of the soman analog was four 
orders of magnitude greater than it was for the corresponding SpSc isomer.  The two 
diastereomers with the Rp configuration were better substrates than the two diastereomers 
with the Sp configuration.  Moreover, the Rc isomer of the chiral pinacoyl substituent was 
preferred in both pairs of diastereomers by a factor of about 10 over the Sc configuration. 
A comparison in the rates of overall turnover for the soman analog with the sarin 
analog clearly showed that the pinacolyl substituent was tolerated less well within the 
active site of the wild type enzyme than was the i-propyl group.  For example, the Rp 
isomer of the sarin analog was hydrolyzed about two orders of magnitude faster than the 
RpRc isomer of the soman analog.  A similar difference was found in the corresponding 
values of kcat/Km.  The data collected in this investigation also demonstrated that the wild 
type PTE hydrolyzed the two stereoisomers of the most toxic analogs of soman 
significantly more slowly than the analogs of the two least toxic stereoisomers.  If PTE is 
going to be an effective reagent for the catalytic destruction of soman then the rate of 
hydrolysis of the most toxic stereoisomers must be significantly enhanced through site-
directed and combinatorial mutagenesis.  For the SpSc enantiomer, an increase in kcat and 
kcat/Km of nearly 4 orders of magnitude should be obtainable.  The catalytic properties of 
the I106A-F132A-H257Y mutant with the analogs of the two Sp diastereomers of soman 
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showed that such gains in catalytic activity are likely to be achieved.  This mutant had a 
50-fold enhancement in the value of kcat and a 75-fold increase in kcat/Km for the SpSc 
enantiomer of soman. 
 
Enzymatic Hydrolysis of the Nerve Agents, Sarin and Soman 
In preliminary experiments conducted in collaboration with Drs. Steven Harvey 
and Joseph DeFrank of the Edgewood Chemical and Biological Center, the wild type 
PTE, in addition to the I106A-F132A-H257Y and G60A mutant enzymes, has been 
shown to catalyze the hydrolysis of racemic mixtures of sarin and soman.  The time 
courses have also been shown to be bi-phasic and thus consistent with differential 
turnover rates for the individual enantiomers.  Turnover rates exceeded 1000 s-1 for the 
I106A-F132A-H257Y mutant PTE with racemic sarin.  This value is three times larger 
than is the value of the wild type enzyme but the catalytic constants for the individual 
enantiomers have not, as yet, been determined.  For racemic soman, the G60A mutant has 
a turnover number that is greater than 10 s-1 and is approximately three times faster than 
the wild type enzyme.  The turnover numbers for the sarin and soman analogs measured 
in the investigation reported here were very similar to the preliminary values obtained for 
sarin and soman themselves.  Therefore, the utilization of the chiral enantiomers in the 
development of novel mutants of PTE with enhanced catalytic activities will be 
productive.  Experiments designed to sample a larger fraction of amino acid sequence 
space within the vicinity of the two binding subsites of PTE will be described in the 
following chapters.  
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CHAPTER III 
EVOLUTION OF PTE TOWARDS EFFICIENT  
SOMAN HYDROLYSIS 
 
Introduction 
Directed Evolution 
There are several protein engineering techniques that can be used to "breed" a 
desired feature or characteristic into an existing protein.  Traditionally, the methods that 
have been used extensively in the past involve rational site directed mutagenesis.  By 
examining the position of an inhibitor complexed within the enzyme active site, obvious 
key residues were identified from crystal structure data.  Those residues were then 
targeted for manipulation in structure-function studies.  However, there are limitations for 
the success of this methodology because relatively few residues are seen as important, as 
initially determined by the 3-D structure.  These limitations have led to the development 
of newer techniques.  Semi-rational mutagenesis techniques incorporate the possibility 
that functionally and catalytically important residues may not be obvious from examining 
the 3-D crystal data alone.   
One example of this applied methodology was seen with directed evolution 
studies of cytochrome P450 BM-3 from Bacillus megaterium (Glieder et al., 2002).  The 
wild type P450 BM-3 acts as a monooxygenase for medium-chain (i.e. C12-C18) fatty 
acids in the presence of oxygen and NADPH.  However, it has very low activity with 
octane, as determined by colorimetric assays with p-nitrophenoxy octane as the alkane 
substrate.  After several generations of random mutagenesis, the mutant 139-3 was 
   
 
58
isolated and identified as having the fastest alkane hydrolase activity of any known 
enzyme (Glieder et al., 2002).  This particular mutant had a total of eleven amino acid 
substitutions, of which only one residue was in direct contact with the substrate as 
implied by the 3-D structural data (Glieder et al., 2002).   
Screens and selections are necessary for detecting the desired characteristic of 
mutants in directed evolution experiments (Olsen et al., 2000).  Both techniques require 
the use of a marker to indicate the presence or absence of a particular feature.  The 
process of screening is more time consuming and less efficient than a selection.  In a 
screen, all phenotypes must be sampled as seen in the “blue-white” screen, which screens 
for bacteria that have lost the ability to digest x-gal.  This particular screen has been 
particularly useful to detect the interruption of a multiple cloning site (MCS) within a 
selectable marker region of a plasmid, so that the disruption (e.g. insertion of a portion of 
a gene) of the MCS would result in the formation of a white colony forming unit (CFU).  
The bacteria that are able to digest the sugar form a blue CFU.  This is a useful technique 
if the sample number is relatively small.  If a large number of samples were to be 
surveyed, the use of a selection would be more practical.  In a selection, the desired 
phenotype is physically linked to survival, which results in the removal of all unwanted 
phenotypes.  As an example, plating on an ampicillin plate will allow only bacteria that 
have ampicillin resistance to grow. 
  
Directed Evolution of PTE 
 PTE is a good candidate for future use in decontamination applications for a 
number of reasons.  The structure of the enzyme has been determined, and many 
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biophysical studies have been done, elucidating the structure-function relationship 
(Benning et al., 1995)(Chen-Goodspeed et al., 2001a,b).  Other appealing aspects of this 
protein are its thermodynamic stability and its ability to be produced in quantity 
(Grimsley et al., 1997).  Of the available nerve agent detoxifying proteins, it is the only 
one that is capable of cleaving phosphorus-oxygen, phosphorus-fluorine, phosphorus-
sulfur, and phosphorus-cyanide bonds (Di Sioudi et al, 1999).  In addition, PTE has 
already been shown to successfully act as a protective agent when injected into mice 
before nerve agent exposure (Tuovinen et al., 1994).  However, the obstacle that remains 
to be solved is improving the rate of hydrolysis for which the enzyme catalyzes reactions.  
To date, the optimum PTE mutant hydrolyzes soman (GD) at the rate of 40 s-1 (Steven P. 
Harvey, personal communication).  In order for PTE to become fully effective at 
detoxifying the nerve agents, the catalytic activity of the enzyme must be significantly 
enhanced.  It is believed that the enzymatic properties of this protein may be greatly 
improved via directed mutagenesis experiments.  In this chapter, efforts directed at 
enhancing the catalytic efficiency of hydrolysis for the toxic isomers of the soman (GD) 
analog will be described.  
 
Materials and Methods 
Mutagenesis 
The plasmid, pJWO1, was derived from a pBS+ vector (Stratagene) and designed 
to contain the opd gene without the 29 amino acid leader sequence.  This construct served 
as the template for all of the following genetic manipulations, and the map of the 4.1 kb 
plasmid is shown in Figure 3.1.   
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Figure 3.1.  A map of the plasmid, pJW01, shows a multiple cloning site similar to that of 
pUC 18, as well as ampicillin resistance (ApR), and the lacZ gene.  This map was 
constructed using Savvy, a plasmid drawing program available by SeWeR at the 
following web address (http://www.bioinformatics.org/savvy/cgi-bin/savvy.cgi)  
(Basu, 2001). 
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Protein libraries were constructed by random mutagenesis methodology, 
involving the use of degenerate oligonucleotides targeting specific regions within the 
gene.  Single and double substitution libraries were constructed by either cassette 
mutagenesis or Quikchange mutagenesis (Stratagene).   For cassette mutagenesis, unique 
restriction sites on either side of the target region were identified and excised within the 
vector, pJW01.  All restriction enzymes were obtained from New England Biolabs.  
Isolation of the restricted fragment was done by gel electrophoresis, and subsequent 
purification was performed by following the protocol for DNA purification (Promega 
Wizard DNA Purification Kit).  The appropriate cassettes containing degenerate 
oligonucleotides for the codon corresponding to the targeted position(s) were obtained 
from the Gene Technologies Laboratory at Texas A&M University.  In the case of 
Quikchange mutagenesis, a set of primers containing degenerate oligonucleotides was 
designed to amplify the desired linear product.   
For the randomization at each position, two oligonucleotides were used and the 
randomization is coded as N or S within each primer, in which N is either A, T, C, or G 
and S is either G or C.  The primers are listed in Table 3.1.   
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Ligation of the cassette with the restricted gene was preformed at 16 °C 
overnight, using T4 DNA Ligase (New England Biolabs).  Transformation was 
performed by electroporation, and the resulting variants were inserted in BL21 (DE3)  
E. coli cells and plated on Luria-Bertani Broth (LB) ampicillin plates.  Following  
mutagenesis, PCR sequencing of the resulting transformants was performed to ensure 
randomness of sample.   
 
Culture Growth Conditions and Screening 
The resulting colony forming units (CFU) were inoculated into deep 96-well 
plates containing super broth (SB), 0.1 mM CoCl2 and 100 µg/mL ampicillin, and 
incubated at 30 °C, shaking at 250 rpm for approximately 40 hours.  The culture was 
diluted 10-fold and the cell density was measured spectrophotometrically at 600 nm.  A 
small portion of the sample (i.e. 25 µL) of the diluted culture was used to test for 
paraoxonase activity, in which the resulting p-nitrophenol product was detected 
spectrophotometrically at 400 nm.   
Each of the following substrates, GD analog racemate, the Sp pair of isomers, and 
the individual SpSc isomer, was tested.  Throughout each assay, the same buffer 
conditions were maintained: 50 mM CHES, pH 9.0, 1% (v/v) Bugbuster (Novagen), and 
0.1 mM substrate.  However, more of the cell culture was used for slower substrates.  For 
example, 25 µL of culture was used for the Sp pair of isomers and the SpSc isomer of the 
GD analog. The chemical structure of each individual isomer of GD, as well as the 
corresponding isomer for the GD analog, is shown in Scheme 1.   
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Scheme 1.  The structures of the individual stereoisomers of soman (I) and the 
corresponding stereoisomers of the soman analog (II) used in this study. 
 
Enzyme Purification 
Both the mutants and the wild-type were expressed in Escherchia coli BL21 cells 
and grown in LB, which was used to inoculate terrific broth (TB) supplemented with 
cobalt chloride.  Expression of protein was induced by the addition of IPTG to a final 
concentration of 0.6 mM after 24 hours of incubation at 30 ºC.  The cells were harvested 
40 hours post induction, and PTE was purified according to the published protocol 
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(Omburo et al., 1992).  SDS-PAGE indicated that the purified mutants were the same size 
as the wild-type PTE and were at least 95% pure. 
 
Kinetic Measurements and Data Analysis 
The enzymatic hydrolysis of the GD analog (p-nitrophenyl pinacolyl methyl  
phosphonate) was measured by monitoring the accumulation of p-nitrophenol at  
400 nm (ε = 17,000 M-1 cm-1) at pH 9.0, 25 °C using a Gilford Model 260 
spectrophotometer.  The enzyme activity was measured in 50 mM CHES, pH 9.0 
containing 10 % methanol for the GD analog.  One unit of activity is defined as the 
amount of enzyme required to catalyze the hydrolysis of one µmol of paraoxon per 
minute.  The kinetic constants were obtained by fitting the data to Equation 3.1, where 
v is the initial velocity, kcat is the turnover rate, A is the concentration of substrate, and Km 
is the Michaelis constant. 
 
 v / Et = kcat A/ (Km + A)    (3.1) 
 
Enzyme assays involving nerve agent were done at Edgewood Chemical 
Biological Center by Dr. Steven P. Harvey, and conducted with a fluoride electrode 
attached to a Fisher Accumet 925 meter.  Reactions were conducted in a temperature-
controlled vessel in a total volume of 5 mL.  Buffering was provided by a 50 mM 
solution of bis-tris-propane, pH 7.2.   
Kinetic parameters were determined from assays conducted at 25 °C.  EZ-FitTM 
version 5.03 software was used for determination of kinetic, and the accompanying 
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statistical analyses.  EZ-FitTM uses the Nelder-Mead simplex and Marquardt nonlinear 
regression algorithms sequentially to determine the kinetic parameters from the 
Michaelis-Menten plot of velocity versus substrate concentration.  The program relies 
upon using two regression methods in tandem to fit the kcat, Km, and inhibition data to a 
non-linear curve. 
 
Time Course Ratios 
The ratios of rates of hydrolysis for each isomer within the racemic GD analog 
were determined for a group of 17 mutants and the wild type enzyme.  A series of 7 serial 
dilutions were made for each enzyme.  Each concentration was assayed with 60 µM 
racemic GD analog buffered in a 50 mM CHES, pH 9.0 solution.  Hydrolysis of the 
solution was spectrophotometrically determined by following the appearance of the p-
nitrophenol leaving group at 400 nm.  The data were fit to Equations 3.2 and 3.3 using 
SigmaPlot2000, and the amplitudes and rates were recorded.  The rates were used in 
calculating the observed time course ratios.      
 
y = y0 + a(1-e-bx)     (3.2) 
Equation 2.  The equation describing a single exponential curve, in which y0 is the y-
intercept, a is the amplitude of the curve, b is the rate constant, and x is a variable and the 
exponent.   
 
y = y0 + a(1-e-bx) + c(1-e-dx)    (3.3) 
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Equation 3.3.  The equation describing a double exponential curve, in which y0 is the y-
intercept, a and c are the amplitudes of the curve, b and d are the rate constants, and x is a 
variable and the exponent.   
 
Results 
Construction of the Single Substitution Libraries 
A single substitution library was constructed for positions His254, His257, 
Leu271, Ser308, Tyr309, Met317, Gly60, and Ile106 by using the method of Quikchange 
with degenerate oligonucleotides targeting a specific residue.  Sample randomness was 
confirmed by sequencing selected CFUs from each library, and is shown in Table 3.2.  
Transformants from each library were inoculated into two deep, 96-well growth plates 
containing SuperBroth.   
In addition to the transformants, PTE mutants with established kinetic constants 
were inoculated into each culture plate as standards.  The standards used in each library 
always included the wild type enzyme.  Each library was screened with paraoxon, the 
racemic GD analog, the Sp pair of isomers of the GD analog, and the individual SpSc 
isomer.  The results from the crude assay were determined in units of mA400 min-1, and 
were adjusted based on the cell density at 600 nm.  In general, cell growth variation of 
0.5 to 0.7 AU was observed after a 10 µL of culture was diluted 25-fold.  Vertical plots 
were constructed showing the normalized activity of the mutants with the library and the 
standards, and shown in the following figures for the Sp pair of isomers of the GD analog 
and the individual SpSc isomer.  There was little variation in activity for the hydrolysis of 
paraoxon and the racemic GD analog, and the results are not shown.   
   
 
68
Table 3.2.  The identities of 5 colony forming units (CFU) isolated from each single 
substitution library.   
 
 
 
 
ProCCGSerTCCAlaGCGAlaGCT
TrpTGGValGTCIleATCValGTG
GluGAGLeuCTCThrACGTrpTGG
ArgAGGProCCCLeuCTCGluGAA
AspGACCysTGCLeuCTGPheTTT
wild typeATCwild typeGGTwild typeATGwild typeTAC
Ile 106Gly 60Met 317Tyr 309
PheTTCAlaGCGMetATGCysTGC
SerTCCIleATCAlaGCGValGTG
ArgAGGValGTGGlyGGGArgAGG
ProCCCProCCGArgCGALysAAG
LeuCTC GlnCAGArgAGGSerAGC
wild typeAGCwild typeCTGwild typeCACwild typeCAC
Ser 308Leu 271His 257His 254
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The H254X single substitution library was screened with paraoxon, the racemic 
GD analog, the Sp pair of GD analog isomers (SpRc/SpSc-(II)) and the individual SpSc 
isomer.  However, there was very little variation for hydrolysis of paroxon and the 
racemic GD analog (results not shown).  The results for the hydrolysis of the Sp isomers 
and the SpSc isomer are shown in Figure 3.2, in which the standards used were wild type, 
G60A, I106A-F132A-H257Y, and H254G-H257W.  The activity of the wild type was 
much higher than expected for the hydrolysis of the Sp pair of isomer.  In the other 
libraries described, the relative order of activities is such that H254G-H257W is greater 
than I106A-F132A-H257Y, which is greater than wild type, which is greater than G60A.  
The screen results indicated the activity of all library members within H254X was equal 
to or lower than the activity of the known standards.  Several of the most active samples 
were identified as having a His, Ala, or Arg at position 254.   
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Figure 3.2.  The results from the GD analog hydrolysis assays for the H254X single 
substitution library.  The library was screened with SpRc/SpSc-(II) (A) and with SpSc-(II) 
(B).   
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The H257X library was screened with the Sp pair of GD analog isomers and the 
individual SpSc isomer.  The standards used were wild type, H254A, H254Q-H257F, 
I106A-F132A-H257Y, and H254G-H257W, and they are shown in blue in Figure 3.3.  In 
comparison to other libraries, there is variation between the levels of activity of the 
standards and little differentiation among them in this library.  In most cases, the activity 
of wild type shows up among the background when assayed with the two slow substrates, 
the Sp pair and the SpSc isomer, and the relative order of activity is such that H254G-
H257W-L303T is greater than H254Q-H257F, which is greater than I106A-F132A-
H257Y, which is equal to H254A, but greater than wild type.  However, results from this 
assay indicate that H2545Q-H257F has the highest activity of the standards for the 
hydrolysis of the Sp pair of isomers, and there is little discrepancy among the remaining 
standards.  Many of the samples screened had activity equal to that of the parent wild 
type, which was higher than expected in the assay.  The two members that were isolated 
for having increased activity for GD analog hydrolysis were identified as H257Y and 
H257W.  
The L271X library was screened with the Sp pair of GD analog isomers and the 
individual SpSc isomer.  The standards used were wild type, G60A, I106A-F132A-
H257Y, and H254G-H257W.  Results from the assays imply that H254G-H257W has the 
highest activity among the standards, followed by I106A-F132A-H257Y, and then wild 
type and G60A.  The activity of all members was approximately the same as wild type 
for both the Sp pair of isomers and the SpSc isomer.  None were higher than the I106A-
F132A-H257Y or H254G-H257W standards.  Two CFUs previously identified by 
sequencing were L271Q and L271A, as shown in Figure 3.4. 
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Figure 3.3.  The results from the crude culture screen for the H257X single substitution 
library.  The library was screened with SpRc/SpSc-(II) (A) and with SpSc-(II) (B).   
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Figure 3.4.  The results from the crude culture screen for the L271X single substitution 
library.  The library was screened with SpRc/SpSc-(II) (A) and with SpSc-(II) (B).   
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The S308X library was screened with the Sp pair of GD analog isomers 
(SpRc/SpSc-(II)) and the individual SpSc isomer.  However, there was relatively poor 
growth with this library as compared to other libraries, in terms of cell density 
spectrophotometrically determined at 600nm.  While growth in other libraries was 
consistently around 0.5 to 0.7 AU at 600nm, the growth in the S308X library was slightly 
lower at 0.3 to 0.6 AU.  Repeated attempts also resulted in poor cell growth.  Standards 
used in this library included wild type, G60A, I106A-F132A-H257Y, and H254G-
H257W.  The H254G-H257W standard had the highest activity, followed by I106A-
F132A-H257Y.  Though, the activities of both wild type and G60A were significantly 
lower than other samples and do not register for the assay with the Sp pair of isomers, 
they do appear in position numbers 18, 23, and 42, 47 of the assay plate for the hydrolysis 
of the SpSc isomer in Figure 3.5.  Many members of this single substitution library had 
very low activity for the Sp pair of isomers, as well as for the individual SpSc isomer.  
S308A was identified as having enhanced activity with the Sp pair of isomers, and was 
identified at positions 53 and 78 of the assay plate.   
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Figure 3.5.  The results from the crude culture screen for the S308X single substitution 
library.  The library was screened with SpRc/SpSc-(II) (A) and with SpSc-(II) (B).   
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The same standards were used for the Y309X single substitution library shown in 
Figure 3.6. The I106A-F132A-H257Y standard had the highest activity for the hydrolysis 
of the Sp pair of isomers, followed by I106A-F132A-H257Y, G60A, and wild type.  
However, the order of relative activities was different for the hydrolysis of the SpSc 
isomer, for which H254G-H257W had the highest activity, followed by I106A-F132A-
H257Y, wild type, and then G60A.  Members of this library had activity equal or lower 
than the wild type parent, with the exception of Y309F and Y309W.  Y309F had the 
highest activity for hydrolysis of the Sp pair of isomers, but did not appear as having 
enhanced activity for individual SpSc isomer.  In contrast, the mutant Y309W had 
enhanced activity for the individual SpSc isomer, but no activity for the SpRc/SpSc pair of 
isomers. 
The M317X single substitution library was screened with the Sp pair of GD 
analog isomers, as well as the individual SpSc isomer.  The standards used were wild 
type, G60A, I106A-F132A-H257Y, and H254G-H257W, and the results are shown in 
Figure 3.7.  The relative order of activities for the hydrolysis of the Sp pair of isomers 
indicated that I106A-F132A-H257Y was greater than H254G-H257W, which was greater 
than wild type and G60A.  Results from the hydrolysis of the individual SpSc isomer 
indicate the same order.  No significant increase in activity was observed with any 
member of the library.  Two samples identified as having activity similar to the wild type 
parent were M317L and M317 (i.e. wild type). 
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Figure 3.6.  The results from the crude culture screen for the Y309X single substitution 
library.  The library was screened with SpRc/SpSc-(II) (A) and with SpSc-(II) (B).   
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Figure 3.7.  The results from the crude culture screen for the M317X single substitution 
library.     The library was screened with SpRc/SpSc-(II) (A) and with SpSc-(II) (B). 
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The G60X and I106X single substitution libraries were screened together on one 
plate, as shown in Figure 3.8.  The standards used in the assays were wild type, H254Q-
H257F, and H254G-H257W-L303T.  Results from the assay with the Sp pair of isomers 
indicated that H254Q-H257F had the highest activity, followed by H254G-H257W-
L303T, and then wild type.  The order was different for the hydrolysis of the SpSc isomer.  
The triple mutant H254G-H257W-L303T had the highest activity, which was greater than 
H254Q-H257F, which was in turn greater than wild type.  The G60T, I106A, and I106S 
mutants were identified as having increased activity for the hydrolysis of both the Sp pair 
of isomer and the individual SpSc isomer.  The mutant I106G, located in position 55, was 
also identified as having enhanced activity for the hydrolysis of the SpSc isomer, and the 
G60V mutant had activity similar to wild type.   
 
The Double Substitution Library, [H254X-H257X] 
Results from previous experiments described by Chen-Goodspeed et al. indicated 
that certain residues within the active site were critical for determining stereoselectivity 
of the enzyme (Chen-Goodspeed et al., 2001a, b). 
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Figure 3.8.  The results from the crude culture screen for the G60X and I106X single 
substitution libraries.  Both libraries were screened with SpRc/SpSc-(II) (A) and with SpSc-
(II) (B). 
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An example of this was seen with the triple mutant, I106A-F132A-H257Y described in 
that investigation.  By decreasing the space available within the large subsite, while 
increasing the space available in the small subsite, the stereoselectivity of the enzyme 
was reversed in relation to wild type PTE.  In particular, positions His254 and His257 
were among the critical residues in the large subsite, and Gly60 was one of the residues 
in the small subsite.   
Randomizations at positions His254 and His257 were made in three different 
parent constructs; wild type, G60A, and L303T.  The PCR sequencing results for each 
double substitution library are shown in Table 3.3.  Twelve plates were screened for the 
double substitution libraries made in wild type and L303T, and two plates were screened 
for the double substitution library made in G60A.  Similar results were obtained for the 
libraries made from the wild type and L303T parents.  In both, several mutants containing 
either an Arg or Gly at position 254 were found to have an increase in catalytic activity 
for the Sp GD isomers, as seen with the following figures.  No samples within the 
[H254X-H257]-G60A exhibited improvements with the substrates tested. 
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Table 3.3.  The identities of 5 colony forming units (CFU) isolated from each double 
substitution library.   
 
 
 
ThrACTTermTAA
SerAGTValGTG
GlnCAGGlyGGG
SerTCGLeuTTG
AspGACAlaGCT
wild typeCACwild typeCAC
G60A-[H254X-H257X]
HisCACIleATC
GlyGGGCysTGT
ValGTTLysAAG
SerAGCGlyGGG
ArgAGGProCCT
wild typeCACwild typeCAC
[H254X-H257X]-L303T
TrpTGGPheTTT
ProCCACysTGT
ArgAGASerAGT
LeuCTALysAAA
LeuCTTHisCAT
wild typeCACwild typeCAC
H254X-H257X
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The H254X-H257X library was first created using the wild type as the parent.  
The standards within each assay plate were wild type and H254R.  Although wild type 
does not appear in Figures 3.9 and 3.10, it is present at positions 19 and 22 for both 
figures.  Figure 3.9 represents plate 3, and Figure 3.10 represents plate 6 of the twelve 
plates screened.  In Figure 3.9, the mutants H254Q-H257F and H254G-H257W have 
enhanced activity for hydrolysis of the SpRc/SpSc isomers.  The H254G-H257W was also 
identified as having increased activity for the individual SpSc isomer, as well as the 
similar H254G-H257R double mutant.  Results from Figure 3.10 indicate that H257Y had 
the highest activity for hydrolysis of the Sp pair of isomer, followed by the double mutant 
H254R-H257A.  H254R was also identified in the assay, in addition to the two other 
H254R standards within the plate.  The results were similar with the assay of the 
individual SpSc isomer, in which H257Y had the highest activity, followed by H254R-
H257A.  The only difference is that the double mutant H254R-H257L appeared to have 
high activity for this substrate, as it appears twice on the same plate at positions 4 and 55, 
but does not appear in the assay with the Sp pair of isomers.  The H254R-H257L mutant 
has also been determined as having enhanced activity for GD analog hydrolysis in studies 
conducted by the Wild Laboratory (Lai, 1994).  
 
 
   
 
84
Sample
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100
N
or
m
al
iz
ed
 A
ct
iv
ity
 (m
A
40
0 
m
in
-1
)
0
2
4
6
8
10
12
14
H254Q
H257F
H254G
H257W
A
H254R
Sample
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100
N
or
m
al
iz
ed
 A
ct
iv
ity
 (m
A
40
0 
m
in
-1
)
0
1
2
3
4
H254G
H257R
H254G
H257W
B
H254R
H254R
 
Figure 3.9.  The results from the GD analog hydrolysis assays for plate 3 of the H254X-
H257X double substitution library.  The library was screened with SpRc/SpSc-(II) (A) and 
with SpSc-(II) (B).   
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Figure 3.10.  The results from the GD analog hydrolysis assays for plate 6 of the H254X-
H257X double substitution library.  The library was screened with SpRc/SpSc-(II) (A) and 
with SpSc-(II) (B). 
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In the H254X-H257X library, many of the mutations found to have improved 
activity for Sp GD hydrolysis had either an Arg or Gly at position 254.  The following 
double mutations were of this description: H254R, H254R-H257A, H254R-H257L, 
H254G-H257W, and H254G-H257R as shown in Figures 3.9 and 3.10.  Of these 
mutations, both H254G-H257W and H254R-H257A were isolated more than once on the 
basis of observed improvement in the crude assays.   
In the same manner, the double substitution library was constructed in G60A.  
However, only two 96-well plates were assayed because initial testing with the library 
indicated that all samples within the library were far less active than the standards, as 
shown in Figure 3.11.  The standards used in the library were G60A, I106A-F132A-
H257Y, and H254G-H257W.  Wild type PTE was not used as a standard because G60A 
was the parent construct used in this library.  The highest activity was seen with H254G-
H257W, followed by I106A-F132A-H257Y, which was followed by G60A.  There was a 
substantial difference between the activities of H254G-H257W and G60A.  The samples 
that exhibited the highest activity among the library members were identified as having 
the parent genotype, G60A.  Two mutants that were identified as having activity similar 
to the parent G60A were found to have a H254L-H257S double mutation, and a H254Y 
mutation (Figure 3.11).  Almost all of the remaining samples were below that of the 
parent for the assays with the Sp pair of isomers and the individual SpSc isomer.   
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Figure 3.11.  The results from the GD analog hydrolysis assays for the G60A-[H254X-
H257X] double substitution library.  The library was screened with SpRc/SpSc-(II) (A) and 
with SpSc-(II) (B).  Wild type is not used as a standard in this library because G60A is the 
parent construct.   
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From the H254X-H257X library constructed in wild type, the double mutant 
H254G-H257W was identified as having significantly higher activity for the hydrolysis 
of the Sp isomers of the GD analog.  In previous studies by Dr. Craig Hill, this particular 
double mutant was used as the parent for a single substitution library at position Leu303.  
In this manner, the triple mutant H254G-H257W-L303T, was identified as having the 
highest activity for GD analog hydrolysis from the single substitution L303X library.  In 
addition, the triple mutant had the highest kinetic constants for Sp GD analog hydrolysis 
of any PTE mutant.  To confirm the finding of the H254G-H257W-L303T mutant, the 
double substitution library was constructed using L303T as the parent.   
The H254X-H257X library was constructed in L303T, and the standards used 
throughout the assays were wild type, G60A, I106A-F132A-H257Y, H254G-H257W, 
and H254G-H257W-L303T.  Twelve plates were screened for this library.  In the 
SpRc/SpSc hydrolysis assay plot shown in Figure 3.12, the H254G-H257W-L303T 
standard and the H254R-L303T appeared to be the most active.  The triple mutant 
standard also appeared to have the highest activity for hydrolysis of the individual SpSc 
isomer.  Both H257Y-L303T and H254R-H257A-L303T appeared to be higher than 
H254G-H257W, but not H254G-H257W-L303T.    
Many mutants obtained from the crude screen assays with enhanced activity for 
SpRc/SpSc isomers hydrolysis had an Arg at position 254, such as H254R-L303T, H254R-
H257S-L303T, and H254R-H257A-L303T.  The H257Y-L303T mutant and the three 
previously mentioned mutants were purified and the kinetic constants were determined 
for the individual GD analog isomers as reported in Table 3.4. 
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Figure 3.12.  The results from the GD analog hydrolysis assays for the [H254X-H257X]-
L303T double substitution library.  The library was screened with SpRc/SpSc-(II) (A) and with 
SpSc-(II) (B).  
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Table 3.4.  The kinetic constants for the individual GD analog isomers. 
1.6E+030.82.5E+041.37.4E+032.41.3E+043.1H254Q-H257F
1.0E+033.13.4E+04114.6E+020.225.5E+024.9I106A-F132A-H257W
1.0E+031.53.5E+039.77.0E+03113.6E+035.6H257Y
4.2E+037.56.0E+033.28.1E+020.522.5E+0447H254A
5.1E+030.62.8E+0415.1E+042.81.2E+043.1H254R-L303T
3.1E+033.53.4E+04138.1E+03181.3E+0417H254R-H257S-L303T
2.4E+0371.3E+04N/A1.0E+031.74.5E+021.3H254R-H257A-L303T
7.4E+03373.3E+042943.6E+03182.3E+038.3H257Y-L303T
5.0E+021.34.0E+03115.7E+021.27.3E+021.9I106A-H257Y
4.8E+03113.2E+03117.5E+03144.2E+04114S308A
1.7E+031.72.4E+033.51.1E+04101.6E+0462H254G-H257R
4.5E+020.647.9E+034.84.9E+022.51.4E+0214H254G-H257W
3.0E+020.073.8E+046.45.2E+04573.1E+0580H257L
5.9E+034.21.5E+041.76.2E+038.67.3E+0422H254R
9.0E+022.71.1E+04172.0E+032.66.7E+025.3I106A-S308A-H257Y
1.2E+032.19.2E+03115.6E+010.32.8E+020.3I106A-F132A-H257Y
7.1E+000.027.0E+000.075.6E+04331.5E+05120G60A
1.6E+010.043.8E+020.31.2E+044.81.6E+0548wt-PTE
M-1s-1s-1M-1s-1s-1M-1s-1s-1M-1s-1s-1
SpScSpRcRpScRpRc
Protein
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Comparison of Ratios Obtained from Both Kinetic Data and Time Course Data 
A group of 17 PTE mutants, along with the wild type, was selected for purification.  
Throughout four separate kinetic assays, the turnover rate and catalytic efficiency for each of 
the isomers were determined for each protein (Table 3.4).  For many of the mutants tested, 
there were considerable decreases for the catalytic efficiency for the hydrolysis of the RpRc 
and RpSc isomers in comparison to the wild type.  However, significant increases were made 
for the SpRc and SpSc isomers.   
From the catalytic efficiency, the ratio of rates for hydrolysis of each isomer was 
calculated.  For comparison, the ratio of rates for the hydrolysis of each of the isomers was 
determined from time course assays (Table 3.5).  In the time course assays, rates of 
hydrolysis for the individual isomers within the racemic mixture were measured.  For 
example, the wild type protein exhibited a ratio of rates of 13:1, 32:1, and 24:1 corresponding 
to the ratios of RpRc: RpSc , RpSc: SpRc, and SpRc: SpSc isomers, as determined from the 
catalytic efficiency for each of the isomers (Table 3.4).  In comparison, wild type exhibited 
ratios of 13:1, 24:1, and 18:1 for the isomers within a racemic mixture (Table 3.5), as 
determined from the rates calculated in several single and double exponential plots of 
hydrolysis.  An example of the time course derived rates can be seen with the wild type in 
Figures 3.13, 3.14, and 3.15. 
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Table 3.5.  The comparison of ratios obtained from kinetic and time course data. 
 
 
 
1111811658H254Q-H257F
1110.130.131340.460.55I106A-F132A-H257W
11221474H257Y
120.3319110.196H254A
155215102H254R-L303T
1142411134H254R-H257S-L303T
110.320.05150.420.19H254R-H257A-L303T
120.830.08140.480.31H257Y-L303T
119481811I106A-H257Y
10.335510.6729S308A
133121169H254G-H257R
1210.0411810.31H254G-H257W
111923871411261731033H257L
11822013112H254R
1520.0711220.74I106A-S308A-H257Y
1190.060.34180.050.23I106A-F132A-H257Y
12n/an/a11800021428G60A
118432561612475010000wt-PTE
SpScSpRcRpScRpRcSpScSpRcRpScRpRc
Ratios from TimecourseRatios from Kinetic ParametersProtein
   
 
93
 
 
Time (s)
0 2000 4000 6000 8000
A
40
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
 
 
 
 
 
 
 
Figure 3.13.  Wild type-catalyzed hydrolysis of the first two isomers within the racemic 
GD analog.  The amount of protein used was 0.217 µg, and the rates were calculated as 
3.11 x 10-3 s-1 and 2.44 x10-4 s-1, resulting in a 13-fold difference. 
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Figure 3.14.  Wild type-catalyzed hydrolysis of the second and the third isomers within 
the racemic GD analog.  The amount of protein used was 3.475 µg, and the rates were 
calculated as 4.17 x 10-3 s-1 and 1.72 x10-4 s-1, resulting in a 24-fold difference. 
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Figure 3.15.  Wild type-catalyzed hydrolysis of the third and fourth isomers within the 
racemic GD analog.  The amount of protein used was 6.95 µg, and the rates were 
calculated as 8.75 x 10-2 s-1 and 4.97 x10-3 s-1, resulting in a 18-fold difference. 
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Many of the mutants from the H254X-H257X libraries had different 
stereoselectivities with respect to wild type.  For example, the double mutant H257Y-
L303T preferred the stereoisomers of the GD analog in the following order; SpRc, SpSc, 
RpSc, and RpRc, but the ratio between the first and the fourth isomer was significantly 
smaller than the ratio reported for wild type.  
 
Kinetic Constants with Soman 
The six mutants, H254R, H257L, H254G-H257W, H254G-H257R, H254Q-
H257F, and H257Y, were purified and the kinetic constants were determined for the 
individual isomers of the GD analog, which are shown in Table 3.4.  In addition, several 
other mutants were purified and sent to Steven P. Harvey at Edgewood Chemical 
Biological Center for testing with soman (Table 3.6).  Of these, the three double mutants 
containing Gly254 showed the most improvement with H254G-H257L having the highest 
Vmax of the group, reported as 28 µmolmin-1mg.  However, the double mutants H254A-
H257W and H254R-H257F, appeared to be less active than the wild type. 
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Table 3.6.  Maximal velocity for PTE catalyzed hydrolysis of the nerve agent GD (S.P. 
Harvey, personal communication).   
 
 
 
1.288H254G-H257Y
4.7428H254G-H257L
0.714H254A-H257W
2.7116H254G-H257W
0.412H254R-H257F
1.086H254R
3.2219G60A
1.107S308A
1.036I106A-F132A-H257Y
1.167I106A-H257Y-S308A
1.066H257Y
2.2013H254A
0.473I106A-H257Y
1.006wild type
Activity Relative to wild typeVmax (µmol min-1 mg)Protein
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Discussion 
Targeting the Sp Isomers of the GD Analog within the Single Substitution Libraries 
In considering the toxicity elicited by the nerve agent GD, there are only two 
isomers that are biologically relevant - the SpRc and SpSc isomers.  The remaining two Rp 
diastereomers are rarely detected long after exposure, and are believed to be readily taken 
up by carboxylesterases present in blood (Langenberg et al., 1998).  Therefore, directed 
evolution studies on PTE have focused on improvements for hydrolysis and 
detoxification of the Sp pair of isomers. 
Based upon previous studies, it is believed that modifications in the large subsite 
of the active site would be beneficial to substrates with large substituents such as GD and 
VX.  The residues His254, His257, and Met317 are found in the large subsite.  Gly60 and 
Ile106 are located in the small subsite.  Tyr309 is in the leaving group pocket, and Ser308 
is found between the small subsite and the leaving group pocket.  
There were only a couple of mutants identified from the H254X library as having 
enhanced activity for the SpRc and SpSc isomers.  The best mutant obtained was H254R, 
followed by H254A.  Other samples isolated had a His at position 254.   
The beneficial modifications identified from the H257X library were very 
conservative in comparison to wild type.  The identification of H257Y and H257W 
indicated that an aromatic amino acid at position 257 is favored for enhanced catalytic 
efficiency of SpRc/SpSc isomer hydrolysis.  In comparison to wild type, the catalytic 
efficiency for SpRc and SpSc hydrolysis was increased 57- and 88-fold, and 14- and 15-
fold greater for H257Y and H257W, respectively.  Although both mutants appeared to be 
faster than the H254Q-H257F standard in the crude assay shown in Figure 3.3, the 
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catalytic efficiency for the SpSc isomer was approximately the same and no improvement 
for the hydrolysis of the SpRc isomer was seen with the kinetic data shown in Table 3.4.  
The difference is attributed to either variation in expression levels for the different 
mutants, or inaccuracy associated with the intrinsic nature of a crude assay.   
Screening of the L271X library resulted in no mutants with enhanced activity.  
Both assays were consistent in this finding.  The standards of H254G-H257W and I106A-
F132A-H257Y appeared distinct from the background, which again, confirms that no 
mutant in this library had enhanced activity for the Sp pair of isomers or the SpSc isomer. 
Results from the S308X library indicated that substitution at this position is 
detrimental for hydrolysis of the Sp isomer of the GD analog.  Almost all members were 
unable to hydrolyze the SpRc/SpSc isomers of the GD analog as indicated in Figure 3.5, 
with the exception of S308A.  The kinetic parameters obtained from purified protein 
indicate that the catalytic efficiency for S308A is 8-fold higher for hydrolysis of the 
individual SpRc isomer, and 300-fold higher for hydrolysis of the individual SpSc isomer 
(Table 3.4).  The activity for all other members was substantially lower than the wild type 
for the individual SpSc isomer.    
Beneficial substitutions at the 309 position were quite conservative in relation to 
the tyrosine found in the wild type.  Improvements were seen for the Y309F and Y309W 
mutants, as shown in Figure 3.6.  In comparing the mutants to the wild type, both Y309F 
and Y309W had greater catalytic efficiencies for the Sp pair of isomers, and the 
individual SpSc isomer.  The purified Y309F mutant exhibited a 7- and 53-fold 
improvement for hydrolysis of the Sp pair of isomers and the SpSc isomer the relative to 
the wild type.  The enhancement was slightly higher in Y309W.  There was a 22-and 88-
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fold improvement.  In comparing the mutants to the standard H254G-H257W, Y309F and 
Y309W had 2- and 3-fold better rates for hydrolysis of the toxic SpSc isomer.   
There were no improvements for Sp GD analog hydrolysis from the M317X 
library.  As shown in Figure 3.7, no mutants were identified as having higher activity 
than the standards.  One mutant with activity similar to the parent was identified as 
having a Leu at the position, while M317 (wild type) was also identified among the 
library members through the screening as having activity similar to the wild type 
standard. 
The G60X and I106X single substitution libraries were screened, and a few 
mutants were identified as having enhanced activity.  The mutants G60T and I106S were 
identified as having enhanced activity for hydrolysis of the Sp pair of isomers.  However, 
the background within the assay for hydrolysis of the SpSc isomer was very high and the 
identification of enhanced mutants was seen as a false positive.  In addition, both residues 
are in the small subsite unlike the other previous single substitution libraries.  
 
Targeting the Sp Isomers of the GD Analog within the H254X-H257X Libraries 
In the double substitution library H254X-H257X made in both the wild type and 
L303T construct, significant enhancements in catalytic activity were seen with 
manipulation of the large subsite residues, 254 and 257.  The three mutants, H254G-
H257W, H254G-H257R and H257Y, appeared to have the highest activity against the Sp 
pair of isomers and the individual SpSc isomer of the GD analog in the H254X-H257X 
library.  They were purified, and the kinetic constants for each substrate were obtained to 
confirm results from the assays.  The H254G-H257W mutant had a catalytic efficiency of 
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4.7 x 103 M-1 s-1 and 4.5 x 102 M-1 s-1 for the Sp pair and SpSc isomer, which was equal to 
a 12- and 28-fold enhancement over the wild type, respectively.  Similar enhancement 
was seen with H254G-H257R.  The catalytic efficiency for H254G-H257R was 12- and 
43-fold higher than wild type for the Sp pair and SpSc isomer, respectively.  The best 
improvement was seen with H257Y, which had a catalytic efficiency of 5.4 x 103 M-1 s-1 
and 1.4 x 103 M-1 s-1, which was equivalent to a 14- and 88-fold enhancement with the Sp 
pair and SpSc isomer, respectively.  Because several of these mutants had enhanced 
activity against the analog, several were sent to Steven P. Harvey at Edgewood Chemical 
and Biological Center for testing with the actual nerve agent (Table 3.6).  Enhancements 
of almost 5- and 3-fold over the wild type were seen with H254G-H257L and H254G-
H257W, respectively (Table 3.6).  However, the mutants H257Y and H254G-H257Y, 
both of which were identified as having increased activity from the crude assays, 
appeared to be just as efficient as the wild type.          
In determining what modifications were beneficial, it was clear that the vast 
majority of the samples with enhanced activity in the assays contained either an Arg or 
Gly at the 254 position.  It was noted that a Gly at position 254 was often accompanied 
by a residue approximately the same size as histidine or larger, as was seen with the 
appearance of H254G-H257W.  Within the double mutations containing Arg at position 
254, there was often a residue that was smaller than histidine, such as H254R-H257A or 
H254R-H257S.  It appears that creating less available space within the large subsite, by 
replacing either His at 254 or 257 with a larger residue, is substantially beneficial for 
hydrolysis of the Sp GD isomers.   
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Several of the same double mutations isolated from the H254X-H257X library, 
were also found in the [H254X-H257X]-L303T library.  Of these were H254R-H257A 
and H254R-H257S, both of which were isolated more than once on the basis of observed 
improvement in the crude assays for both libraries.  In addition, both modifications 
proved to be beneficial for SpRc and SpSc hydrolysis.  As seen in Table 3.4, the purified 
H254R-H257A-L303T exhibited a 34- and 150-fold enhancement in comparison to the 
wild type.  The H254R-H257S-L303T had a 89- and 194-fold enhancement for the 
individual SpRc and SpSc isomers, respectively.  Other beneficial modifications were the 
single mutations H254R and H257Y in L303T.  Although in Figure 3.7 it appeared that 
the H257Y-L303T was less active than both the H254G-H257W and H254G-H257W-
L303T standard, the kinetic data with the purified protein indicated that H257Y-L303T 
was more active.  In fact, there was a 462-fold enhancement for catalytic efficiency 
reported for the SpSc isomer, and a 86-fold enhancement for the SpRc isomer in 
comparison to the wild type.  The enhancement for SpSc hydrolysis was 16 times higher 
than the H254G-H257W standard, and slightly higher than the H254G-H257W-L303T, 
which has a reported value of 7.2 x 103 M-1 s-1 as a kcat/Km (Craig Hill, personal 
communication).  The H257Y-L303T had a 3-fold enhancement for hydrolysis of the 
SpRc isomer in comparison to the standard H254G-H257W-L303T.  The discrepancy is 
believed to be attributed to the inaccuracy associated with the intrinsic nature of a crude 
culture assay.  Aspects such as effectiveness of the detergerent used, and volume of 
media in the growth box might have contributed to variation. 
It was apparent that there was a preference for the placement of an Arg at position 
254 and a Tyr at position 257 among the mutants with improved activity in the [H254X-
   
 
103
H257X]-L303T library.  In comparing these results to the sequence of the opdA gene 
from Agrobacterium, which shares a 90% identity in terms of amino acid sequence with 
opd from Pseudomonas diminuta, there is an Arg at position 254 and Tyr at 257 in the 
wild type (Yang et al., 2003).  In particular, the emergence of Arg at position 254 was 
also noted in error prone PCR experiments using the opd gene, which were described in 
the same study.  However, the evolution of the gene was directed towards hydrolysis of 
coumaphos and methyl parathion (Yang et al., 2003).   
Results from the double substitution library constructed in G60A had clearly 
shown that almost all modifications in the 254 and 257 region were detrimental to 
activity against the Sp isomers of the GD analog.  As discussed in the previous chapter, 
G60A shares the same order of preferential hydrolysis for the GD isomers with the wild 
type protein.  The stereoselectivity exhibited by the parent may have been passed on to 
the members of this library even though modifications in the large pocket are beneficial 
to the rates of hydrolysis for the Sp isomers in the wild type. 
 
Stereoselectivity of Hydrolysis 
As seen in Table 3.5, the wild type preferentially hydrolyzes the RpRc isomer, and 
it does so 10,000 times faster than the toxic SpSc isomer.  The stereoselectivity of the wild 
type is in the direction of RpRc, RpSc, SpRc, and SpSc.  However, this order of preference 
has been changed by several of the mutants obtained from the double substitution 
libraries.  In general, the rates for RpRc and RpSc hydrolysis are fairly broad with most of 
the mutants exhibiting a catalytic efficiency within the range of 102 and 104 M-1 s-1 for 
both of the isomers.  Most of the mutations have detrimentally affected the ability to 
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hydrolyze the Rp diastereomers in comparison to wild type.  The ability to hydrolyze the 
RpRc isomer decreased from 2- to 1142-fold with some of the mutants, as seen with 
H254R and H254G-H257W.  Similarly, the ability to hydrolyze the RpSc was decreased 
from 4- to 245-fold, with the greatest decrease seen with the double mutant, H254G-
H257R.  In contrast, there were significant enhancements seen with the rates for the 
hydrolysis of the individual Sp diastereomers.  As mentioned previously, protein  
engineering experiments were directed towards the hydrolysis of the Sp isomers.  This 
was achieved with the double substitution libraries.  The catalytic efficiency for SpRc 
hydrolysis was in the range of 103 and 104 M-1 s-1, and 103 M-1 s-1 for the SpSc isomer.   
The enhancements were between 34- to 100-fold higher than wild type for the SpRc 
isomer, with the largest improvements demonstrated by H257Y-L303T and H257L.  
More substantial improvements were made for SpSc hydrolysis.  The optimum enzyme 
was H257Y-L303T, with a 462-fold increase in rate.  Both the H254R-H257A-L303T 
and H254R-H257S-L303T mutants had improvements of 150- to 194-fold relative to 
wild type.  In addition, the order of stereoselectivity for many of these mutants was 
changed drastically.  For both triple mutants, SpRc hydrolysis occurred the fastest.  The 
same was true for H254G-H257W, H254G-H257R, and H254Q-H257F.  In addition, the 
double mutant H257Y-L303T preferred both toxic isomers, SpRc and SpSc, over the less 
toxic isomers of RpSc and RpRc.         
Stereoselectivity for hydrolysis was expressed as a ratio of 10,000:750:237:1 for 
the purified wild type protein, in terms of the preference of the RpRc: RpSc: SpRc: SpSc 
isomers within the racemic GD analog.  The ratios for preference of the isomers in terms 
of pairs of isomer was determined to be 13:1, 32:1, and 24:1 corresponding to RpRc: RpSc, 
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RpSc: SpRc, and SpRc: SpSc as determined from the kinetic data.  The time course ratios 
obtained were 13:1, 24:1, and 18:1, shown in Figures 3.13, 3.14, and 3.15.  As seen from 
both ratios, the degree of stereoselectivity was readily observed for the wild type.  
However, mutants obtained from the directed evolution studies had substantially smaller 
ratios of rates.  As seen with H257Y-L303T, the rate of hydrolysis of the fastest isomer is 
only 14-fold greater than the rate of hydrolysis of the slowest isomer, as shown in Table 
3.4.  From the kcat/Km values, the ratio of hydrolysis for RpRc: RpSc was 1:2; for RpSc: 
SpRc the ratio was 1:8; and for SpRc: SpSc the ratio was 4:1.  From the time course 
experiments, the ratio of hydrolysis for RpRc: RpSc was 1:11; for RpSc: SpRc the ratio was 
1:2; and for SpRc: SpSc the ratio was 2:1.  It was apparent from Tables 3.4 and 3.5 that 
improvements for the hydrolysis of the Sp isomers were made at the cost of the ability to 
hydrolyze the Rp isomers.  
 In general, the results from the crude culture assays are not accurate.  The reasons 
include poor growth within the incubation plates, and perhaps variation in protein 
expression.  The method of extracting protein may have also attributed to the variation in 
the assays.  However, the crude assays were successful in the isolation and identification 
of enhanced mutants.   
The intrinsic nature of a screen implies that all samples must be surveyed.  Many 
samples were assayed, and some were positively identified as having enhanced activity 
for the substrates tested, and some were not but the directed evolution experiments are 
aimed at discovering a substantial enhancement of activity for hydrolysis of the toxic Sp 
isomers of GD.  In this manner, any mutant with a substantial enhancement of activity 
would positively be identified through this crude assay system.  
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CHAPTER IV 
DIRECTED EVOLUTION STUDIES AND STEREOSPECIFICITY 
INVESTIGATIONS ON SARIN HYDROLYSIS 
 
Introduction 
Among the six most commonly found chemical warfare agents within the U.S. 
Chemical Munitions Stockpile, sarin (GB) (methyl phosphonofluoridate isopropyl ester) 
has been studied most extensively.  It was first synthesized in 1938 by Gerhard Schrader 
at IG Farben (U.S. Department of Defense, 1998), and is the second of the G agents 
developed.  The discovery of GB followed that of tabun (GA) and preceded soman (GD).  
As a class of nerve agents, the G agents share the characteristics of volatility and extreme 
toxicity.  For instance, the projected model for aerosol dispersion of sarin depicts extreme 
vulnerability due to the compound’s high volatility of 22,000 mg m3 at 20º C, as well as 
projected rapid dispersion (Stewart et al., 2003).  This particular characteristic of the 
compound dictates its ability to rapidly cause toxicity primarily via acute inhalation.  As 
an indication of toxicity, a low observable adverse effect such as miosis is estimated to 
occur at a concentration as low as 3 mg min-1 m3 for 50% of the human population 
(USAMRICD, 1995).    
Although GB is not a concern in terms of stagnancy as in the case of VX, the 
potential use of this agent is of grave concern due to several previous documented uses.  
It is believed that GB is the most easily obtained agent, and that there is a greater 
likelihood for its use in a situation of unplanned release (U.S. Congress, 1993).  For these 
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reasons, the ability of the agent to cause mass casualties and to incite hysteria continues 
to pose a formidable threat to humanity.   
In one such case during the 1980’s, Iranian sources claimed that 50,000 casualties 
and 5000 deaths were caused by the use of nerve agents by Iraq in the Iran-Iraq war 
(Eisenstadt, 1990).   Most of the Iraqi munitions were believed to contain a mixture of 
sarin (GB) and cyclosarin (GF) for greater persistence and toxicity.  Another incident that 
occurred within the past 10 years was the use of GB gas by terrorists from the Aum 
Shinrikyo cult in Tokyo.  The release of GB gas in a subway train led to over 3700 
injuries and 12 deaths (Evison et al., 2002).  Both cases further illustrate the immediate 
need for development of effective detoxification options. 
To date, phosphotriesterase (PTE) is the fastest enzyme for sarin hydrolysis and 
the only one capable of detoxifying the deadly VX nerve agent (Di Sioudi et al., 1999).  
Variants of PTE have been shown to hydrolyze sarin at the rate of 1700 s-1, with a kcat/Km 
of 1.5 x 106 M-1 s-1 (Steven P. Harvey, personal communication).  Other enzymes such as 
butyrylcholinesterase, paraoxonase, and organophosphorus acid anhydrolase (OPAA) 
hydrolyze GB at a much slower rate.  For example, human paraoxonase (PON1) 
hydrolyzes GB at a rate on the order of 102 M-1  s-1, which is almost 3 orders of magnitude  
slower than that of PTE (Josse et al., 2001).  Catalysis by OPAA is also significantly 
slower for the GB analog (methyl isopropyl p-nitrophenyl phosphonate) hydrolysis when 
compared to PTE.  Rates for both the Rp and Sp isomers of the GB analog are on the order 
of 104 greater with PTE (Hill et al., 2001).   
In comparison with other organophosphate hydrolyzing enzymes, PTE is a 
superior candidate for use as a sarinase.  However, stereoselectivity exhibited by the wild 
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type protein is still an issue because of preferential hydrolysis of the relatively non-toxic 
Rp isomer within a racemic mixture.  The difference between the effects of the Rp versus 
the Sp isomers of GB is estimated to be quite substantial, as indicated by both toxicity and 
kinetic data.  The LD50 value for the Sp isomer was 50 times smaller than the LD50 value 
for the Rp isomer when tested with mice (Spruit et al., 2000).   Studies from Benschop et 
al. also indicate a difference of at least 4500-fold between the rate constants for inhibition 
of AChE by the two different GB isomers (Benschop and De Jong, 1988).  
If used unmodified, wild type PTE would in fact potentiate the toxicity of GB by 
hydrolyzing the Rp isomer, thereby increasing the available concentration of the toxic Sp 
isomer.  The issues of differential hydrolysis and toxicities are addressed in this chapter, 
as well as efforts directed at obtaining PTE mutants with an increased ability to hydrolyze 
the Sp isomer of the GB analog.  In addition, the stereospecificity of catalysis within the 
racemic GB analog was investigated for several mutants of PTE as well as the wild type 
protein.   
 
Materials and Methods 
Mutagenesis 
 Mutants were obtained by cassette mutagenesis from both site directed 
mutagenesis studies and the creation of libraries. The pJWO1 plasmid containing the opd 
gene without the leader sequence was used as the template for all genetic manipulations.   
Libraries of mutants were constructed by random mutagenesis methodology, involving 
the use of degenerate oligonucleotides targeting specific regions within a gene.  Double 
substitution libraries were constructed by cassette mutagenesis.  In cassette mutagenesis, 
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unique restriction sites on either side of the target region were identified and excised 
within the vector, pJW01.  The KpnI and NsiI restriction enzymes were obtained from 
New England Biolabs and Promega.  The restricted fragment was isolated by gel 
electrophoresis, and purification was performed according to the protocol for DNA 
Purification (Promega Wizard DNA Purification Kit).  Cassettes containing degenerate 
oligonucleotides for the codon corresponding to the targeted positions of His254 and 
His257 were designed, and then obtained from the Gene Technologies Laboratory at 
Texas A&M University.  The primer for the forward direction was 5’ CTGATCGGTCT 
GGACNNNATCCCGNNNTCCGCTATCGGTCTGG AAGACAATGCA3’, and in the 
reverse direction was 5’ TTGTCTTCCAGACCGATAGCGGANNNCGGGATNNNG 
TCCAGACCGATCAGGTAC3’. 
Ligation of the cassette with the restricted gene was preformed at 16° C 
overnight, using T4 DNA Ligase (New England Biolabs).  The recombinant vector was 
then transformed by electroporation into BL21 (DE3) E. coli cells, and subsequently 
plated on Luria-Bertani Broth (LB) ampicillin plates.  Following mutagenesis, PCR 
sequencing of the resulting transformants was performed to ensure randomness of 
sample.   
 
Culture Growth Conditions and Screening 
The resulting transformants were inoculated into deep 96-well plates that 
contained super broth (SB), 0.1 mM CoCl2 and 100 µg/mL ampicillin.  The growth plates 
were incubated at 30 °C, shaking at 250 rpm.  After 40 hours, the culture was diluted 10-
fold and the cell density was measured spectrophotometrically at 600 nm.  A small 
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portion of the sample (i.e. 25 µL) of the diluted culture was assayed for paraoxon 
hydrolysis, in which the resulting p-nitrophenol product was detected 
spectrophotometrically at 400 nm.  The following substrates were tested in a similar 
manner; GB analog racemate, the Rp isomer, and the Sp isomer.  Throughout each assay, 
the same buffer conditions were maintained: 50 mM CHES, pH 9.0, 1% (v/v) Bugbuster 
(Novagen), and 0.1 mM substrate.  Twelve growth plates, containing library members 
and known standards, were assayed in this manner. 
 
Enzyme Purification 
Both mutants and the wild-type were expressed in Escherchia coli BL21 cells and 
grown in LB overnight.  The resulting culture was used to inoculate terrific broth (TB) 
supplemented with 100 µM CoCl2.  After a 24 hour period of incubation at 30 ºC, the 
addition of IPTG to a final concentration of 0.6 mM induced expression of protein.  The 
cells were harvested 40 hours post induction, and PTE was purified by following the 
protocol described in Omburo et al. (Omburo et al., 1992).  SDS-PAGE indicated that the 
purified mutants were the same size as the wild-type PTE and were at least 95% pure. 
 
Kinetic Measurements and Data Analysis 
The enzymatic hydrolysis of the sarin analog, isopropyl p-nitrophenyl methyl 
phosphonate, was measured by monitoring the accumulation of p-nitrophenol at 400 nm 
(ε=17,000 M-1cm-1) at pH 9.0, 25°C using a Gilford Model 260 spectrophotometer.   
The enzyme activity was measured in 50 mM CHES, pH 9.0 for the sarin analog.  One 
unit of activity is defined as the amount of enzyme required to catalyze the hydrolysis of 
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one µmol paraoxon per minute.  The structures of paraoxon (I) and the isomers of the GB 
(II) analog are shown in Scheme 1. 
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The kinetic constants were obtained by fitting the data to the Equation 4.1, in 
which v is the initial velocity, kcat is the turnover rate, A is the concentration of substrate, 
and Km is the Michaelis constant. 
 
          v / Et = kcat A / (Km+A)     (4.1) 
Enzyme assays involving nerve agent were done at Edgewood Chemical 
Biological Center by Steve P. Harvey, and conducted with a fluoride electrode attached 
to a Fisher Accumet 925 meter.  Reactions were conducted in a temperature-controlled 
vessel in a total volume of 5 mL.  Buffering was provided by a 50 mM solution of bis-
tris-propate at pH 7.2.   
 
Time Course Ratios 
The ratios of rates of hydrolysis for each isomer within the racemic GB analog 
were determined for a group of 18 mutants and the wild type.  Serial dilutions were made 
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for each enzyme, and each concentration was assayed with 60 µM racemic GB analog 
buffered in a 50 mM CHES, pH 9.0.  Hydrolysis of the solution was 
spectrophotometrically determined by the appearance of the p-nitrophenol leaving group 
at 400 nm.  The data were fit to Equations 4.2 and 4.3 using SigmaPlot2000, and the 
amplitudes and rates were recorded.  The rates were used in calculating the observed time 
course ratios.      
 
y = y0 + a(1-e-bx)     (4.2) 
Equation 2.  The equation describing a single exponential curve, in which y0 is the y-
intercept, a is the amplitude of the curve, b is the rate constant, and x is a variable and the 
exponential.   
 
y = y0 + a(1-e-bx) + c(1-e-dx)    (4.3) 
Equation 3.  The equation describing a double exponential curve, in which y0 is the y-
intercept, a and c are the amplitudes of the curve, b and d are the rate constants, and x is a 
variable and the exponential.   
 
Results 
The Double Substitution Library, H254X-H257X 
The double substitution library, H254X-H257X, was constructed using the wild-
type opd gene, and the L303T construct.  Sample randomness was confirmed by 
sequencing.  As an example, the identities of 5 CFUs from each of these libraries are 
shown in Table 4.1.   
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Table 4.1.  The identities of the codons from 5 random colony forming units of the 
H254X-H257X library made in both wild type and L303T. 
 
 
 
 
HisCACIleATC
GlyGGGCysTGT
ValGTTLysAAG
SerAGCGlyGGG
ArgAGGProCCT
wild typeCACwild typeCAC
[H254X-H257X]-L303T
TrpTGGPheTTT
ProCCACysTGT
ArgAGASerAGT
LeuCTALysAAA
LeuCTTHisCAT
wild typeCACwild typeCAC
H254X-H257X
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Twelve growth plates were screened for GB analog hydrolysis activity.  Six of the 
assay plates are shown in the following figures, with several mutants identified on the 
basis of observed enhancement for hydrolysis of the Sp isomer and the Rp isomer.  
In plate B1 of the H254X-H257X library, the standards used were wild type and 
H254R (Figure 4.1).  Results from the Sp isomer hydrolysis assay indicate that H254R 
has greater activity than wild type, but the reverse is true for the Rp isomer hydrolysis 
assay.  In this particular plate, the wild type standard located at position 11 is unusually 
high as compared to the other assay plates within the library.  The mutants obtained from 
this plate were H257Y, H254G-H257D, and H254R-H257L.  The single mutation, 
H257Y, had the highest activity on the plate, followed by H254G-H257D, which was 
similar to activity observed for the H254R standard.  H254R-H257L appeared to have 
activity for the Rp isomer of the GB analog.   
The same standards are used in plate B2, which is shown in Figure 4.2.  H254R 
has the highest activity, followed by H254G, H254R-H257L, and H254R-H257Y.  The 
activity of wild type is relatively low compared to the activity of the members within this 
library.  The normalized activity for wild type is around 100 mA400 min-1, while the 
activity for both H254G and H254R are well above 1000 mA400 min-1.   
The three mutations obtained from the Sp isomer hydrolysis assay also appear in 
the screen with the Rp isomer, in which H254G has the highest activity, followed by 
H254R-H257L, H254R-H257Y, H254R, and then wild type. 
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Figure 4.1.  The results from the GB analog hydrolysis assays for plate B1 of the H254X-
H257X library.  The library was screened with Sp-(II) (A) and with the Rp-(II) (B).   
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Figure 4.2.  The results from the GB analog hydrolysis assays for plate B2 of the H254X-
H257X library.  The library was screened with Sp-(II) (A) and with the Rp-(II) (B). 
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Results from plate B3 are shown in Figure 4.3, in which the standards used are 
wild type and H254R.  Two mutants were obtained from the Sp isomer assay.  The 
H254R-H257M mutant had the highest activity on the plate, followed by the H254R 
standard.  Another sample with enhanced activity was also identified as H254R-H257M, 
as well as a H254R single mutation.  The variation in activity for identical mutants is 
revealed in this plate.  The normalized activity for the H254R-H257M varied between 
1000 to 1400 mA400 min-1, whereas the activity for H254R varied from 800 to 1200 
mA400 min-1.  However, both of the mutants had much higher activities than wild type, 
which was around 200 mA400 min-1. 
The H254R standard had unusually high activity for hydrolysis of the Rp isomer.  
For this particular plate, the activity was around 4000 mA400 min-1, whereas in other 
plates it is generally half that value.  Because of this, the activity of H254R was the 
highest, followed by H254R-H257M, and then wild type.  In the other plates, wild type 
has activity higher than H254R.  
Figure 4.4 shows the results from the Sp isomer assay with plate B4, in which 
H254G-H257Y has the highest activity, followed by the H254R standard.  The H254G-
H257R mutant has slightly less activity, followed by the H257Y mutant.  There is a 5-
fold difference between the activities of wild type and the H254R standard.   
The H254R standard has very high activity for the hydrolysis of the Rp isomer 
assay.  It is approximately 4500 mA400 min-1, where as the activity for wild type is around 
3000 mA400 min-1.  The mutants H254R-H257Y, H254G-H257R, H254G-H257Y, and 
H257Y have lower activity in comparison to wild type.    
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Figure 4.3.  The results from the GB analog hydrolysis assays for plate B3 of the H254X-
H257X library.  The library was screened with Sp-(II) (A) and with the Rp-(II) (B). 
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Figure 4.4.  The results from the GB analog hydrolysis assays for plate B4 of the H254X-
H257X library.  The library was screened with Sp-(II) (A) and with the Rp-(II) (B). 
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In Figure 4.5, the results from plate 4 are shown.  The activity of wild type is 
unusually high for the hydrolysis of the Sp isomer.  In most plates, wild type activity is 
typically under 500 mA400 min-1.  In this plate, it is approximately 800 mA400 min-1.  The 
mutant with the highest activity was H254R, followed by H254R-H257A.  The H254R-
H257V mutant had lower activity than wild type, but also appears in the Rp hydrolysis 
assay.  
The H254R-H257A mutant had the highest activity for the hydrolysis of the Rp 
isomer.  It was higher than wild type, followed by H254R, and then by H254R-H257V.  
Wild type was isolated and identified on the basis of enhanced activity.  The activity of 
wild type was 2200 mA400 min-1, whereas the wild type standard was lower than expected 
at 500 mA400 min-1.        
The results from plate 6 are shown in Figure 4.6.  The H254R-H257A mutant had 
the highest activity for hydrolysis of the Sp isomer.  It was followed by H254S-H257Y, 
which had greater activity than H254A-H257W, and H254R.  The normalized activity for 
H254R-H257A was around 200 mA400 min-1.  There was a relatively small difference 
between the H254R and wild type standards, of only about 200 or 300 mA400 min-1.     
The H254R-H257L mutant appeared three times in the assay with the Rp isomer.  
The activity of this mutant was approximately 200 mA400 min-1, and was significantly 
higher than the standards on the plate.  No other mutant was identified as having 
enhanced activity for Rp isomer hydrolysis.   
 
 
 
   
 
121
Sample
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100
N
or
m
al
iz
ed
 A
ct
iv
ity
 (m
A
40
0 
m
in
-1
)
0
200
400
600
800
1000
1200
1400
wild
type
A
H254R
H254R
H254R
H257V
H254R
H254A
 
Sample
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100
N
or
m
al
iz
ed
 A
ct
iv
ity
 (m
A
40
0 
m
in
- 1
)
0
500
1000
1500
2000
2500
3000
wild
type
B
H254R
H254R
H254R
H257V
H254R
H254A
wild
type
 
 
Figure 4.5.  The results from the GB analog hydrolysis assays for plate 4 of the H254X-
H257X library.  The library was screened with Sp-(II) (A) and with the Rp-(II) (B). 
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Figure 4.6.  The results from the GB analog hydrolysis assays for plate 6 of the H254X-
H257X library.  The library was screened with Sp-(II) (A) and with the Rp-(II) (B). 
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 The H254X-H257X library was constructed in the L303T construct.  Fewer 
mutants were identified as having enhanced activity for isomers of the GB analog.  In 
general, the background of library members was significantly lower than was seen in the 
H254X-H257X library created with the wild type.  Figure 4.7 shows results from the Sp 
and Rp isomer hydrolysis assays.  The standards used were wild type, G60A, I106A-
F132A-H257Y, H254G-H257W, and H254G-H257W-L303T.  The triple mutant I106A-
F132A-H257Y had the highest activity for hydrolysis of the Sp isomer, followed by 
H254G-H257W.  H254G-H257W-L303T had lower activity, but was higher than wild 
type and G60A.  The H254R-L303T and H254R-H257S-L303T mutants were identified 
as having activity higher than other library members within the plate. 
 Activity for hydrolysis of the Rp isomer was higher for the library members.  Wild 
type and G60A were among the samples with the highest activity.  The remaining 
standards had very low levels of activity.  Two mutants isolated after the assay were 
H254C-H257G-L303T and H254R-H257A-L303T. 
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Figure 4.7.  The results from the GB analog hydrolysis assays for the [H254-H257X]-
L303T library.  The library was screened with Sp-(II) (A) and with the Rp-(II) (B). 
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The relative activities of the mutants obtained from the assays were plotted in terms of 
increased activity with the hydrolysis of the Sp isomer of the GB analog, as determined 
from the crude culture assay.  Many mutants with an increased rate in Sp GB analog 
hydrolysis had either an Arg or Gly at the 254 position.  The identities of mutants that 
had an Arg at position 254, and had higher activity were H254R-H257M, H254R-
H257A, H254R-H257L, H254R-H257V, and H254R-H257Y.  Mutants with a Gly at 
position 254 were H254G-H257R, H254G-H257W, H254G-H257Y, and H254G-H257D.  
Other double mutations obtained were H254A-H257W and H254S-H257Y.  In addition 
to the double mutations identified, several single substitution mutants displayed an 
increased rate of hydrolysis for the Sp isomer of the GB analog in comparison to wild 
type.  These included H254G, H254R, and H257Y.   
Several other mutants were chosen from the H254X-H257X double substitution 
library created in L303T.  The mutants that were chosen had shown enhancements with 
the Sp isomers of soman analog screening, and were purified.  The kinetic constants for 
the individual Sp and Rp isomers of the GB analog were determined for each protein, as 
shown in Table 4.2.  The highest kcat/Km values for the Sp isomer were 2.6 x 106 and 1.9 x 
106 M-1 s-1 for H254R-L303T and H254R-H257S-L303T, respectively.  The double 
mutant, H257Y-L303T, had a similar kcat/Km as the wild type.  However, the turnover 
rate for this mutant was almost 10-times higher than that of the wild type.  The lowest 
value for the Sp isomer was 1.1x 104 M-1 s-1, which was reported for H254R-H257A-
L303T.  All members from this library had higher kcat/Km values for the Sp isomer instead 
of the Rp isomer, with the exception of H254R-L303T.  The kcat/Km for the Rp isomer was 
3.7 x 106 M-1 s-1.
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Many of these mutants were purified to homogeneity, and the kinetic constants 
were determined for hydrolysis of the individual isomers of the GB analog.  The mutants 
purified were H254R-H257A, H254Q-H257F, H254G-H257W, H254G-H257R, H254R-
H257A-L303T, H254R, and H257Y.  The mutants H254R-H257S-L303T and H257Y-
L303T were previously obtained on the basis of enhancement observed with hydrolysis 
of the soman analog isomers.   
In particular, three samples that displayed the highest activity were isolated and 
compared to wild type, G60A, and I106A-F132A-H257Y, for Sp GB analog hydrolysis as 
shown in Figure 4.8.  All three were higher than wild type and G60A.  The kcat/Km for Sp 
isomer hydrolysis was 1.2 x 106 M-1s-1, 1.9 x 106 M-1s-1, and 3.1 x 106 M-1s-1 for the 
mutants H257R, H254G-H257R, and H254G-H257W, respectively.  Only the mutant, 
H254G-H257W, was higher than the standard I106A-F132A-H257Y, which had a kcat/Km 
of 2.7 x 106 M-1s-1.  
A total of 18 mutants and the wild type were purified and assayed with both the 
Rp and Sp isomer of the GB analog.  As seen in Table 4.2, there were three individual 
single mutants with kcat/Km values on the order of 106 M-1s-1 for the Sp isomer.  Among 
them, the highest was 6.5x106 M-1s-1 which was observed for H254A.   
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Figure 4.8.  The catalytic efficiency of the purified mutants for the hydrolysis of the Sp 
isomer of the GB analog.  These mutants were obtained from the screening of the 
H254X-H257X library. 
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Time Course Ratios 
 As shown in Table 4.2, the kinetic constants for the individual isomers were 
determined for wild type and 18 mutant proteins.  The turnover rate and catalytic efficiency 
were determined for each protein.  Stereoselectivity was expressed as a ratio of preference 
for the Rp isomer over the Sp isomer, as calculated from the catalytic efficiency for hydrolysis 
of each isomer.  A ratio of 1 would mean that there is equal preference for each isomer.  This 
was obtained for both H254R-L303T and H254R-H257A.  A ratio of 1:367 was reported for 
I106A-F132A-H257W, as the stereoselectivity for this protein has been reversed in 
comparison to wild type.  The triple mutant greatly prefers the Sp isomer over the Rp isomer.   
In comparison to the kinetic ratio, another ratio was determined from time courses 
with the racemic GB analog.  Several serial dilutions of each protein were assayed with the 
racemic GB analog, and the rates of hydrolysis and amplitude(s) of curve were determined 
for each sample.  By comparing each of the time courses, differential rates of hydrolysis of 
the substrate were determined.  The ratios of rates were used in comparison to the kinetic 
ratios.  The experimental ratios from both the individual isomers and the time course were 
similar.   
As an example in Figure 4.9, there is a comparison of two different time courses 
constructed with wild type.  One time course is done with 0.007 µg of wild type protein, and 
the other is done with 0.07 µg of wild type protein.  The rate of hydrolysis as determined 
from the single exponential fit is different for each time course because of the different 
amount of enzymes added.  The rate constants were 9.45 x 10-4 and 9.38x10-3.   
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Figure 4.9.  Two time courses from wild type catalyzed hydrolysis of the racemic GB analog.  
The first (A) is with 0.007 µg of wild type, and the second (B) is 0.07 µg of wild type diluted 
100-times.  By comparing the single exponential equations (red), there is a 10-fold difference 
between the two rates. 
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The rate for each is indicative of the rate for hydrolysis of one isomer.  By comparing both 
plots, the difference in rates is obtained.  In this example, the rate of hydrolysis was 
determined to be a 10.  In comparison, the ratio from the kinetic data indicates there is 
difference of 20 between the catalytic efficiency of the Rp and Sp isomers of the GB analog, 
with the Rp isomer preferred (Table 4.2).   
In comparison, a greater difference can be seen with I106A-F132A-H257W as shown 
in Figure 4.10.  The time courses were constructed with 0.005 µg and 0.45 µg of protein.  
The rate constants were 4.8 x 10-1 and 9.6 x 10-4.  The difference between the rates in the two 
plots was calculated as 505-fold.  The ratio of catalytic efficiencies between the two isomers 
was 367, with the Sp isomer preferred (Table 4.2).     
The wild type and four mutant proteins were sent to Steven P. Harvey at the 
Edgewood Chemical Biological Center, to be assayed with racemic sarin.  Time courses for 
wild type, G60A, I106A-F132A-H257Y, I106A-H257Y-S308A, and I106A-H257Y were 
constructed with 0.5 mM racemic GB.  The concentration of fluorine released over time was 
recorded for each sample, in addition to non-enzymatic hydrolysis of the agent as shown in 
Figure 4.11.  The hydrolysis of racemic GB by wild type, G60A, and I106A-H257Y were 
similar, and could be expressed as a single exponential function.  The plots are shown in 
Figures 4.12, 4,13, and 4.14.  However, hydrolysis catalyzed by both I106A-F132A-H257Y 
and I106A- H257Y-S308A appeared to be biphasic, and expressed as a double exponential 
function, as shown in Figures 4.15 and 4.16.  The difference between rate constants was 22-
fold for I106A-F132A-H257Y and 33-fold for I106A-H257Y-S308A.  To confirm this 
observation, double enzyme plots were constructed using each enzyme. 
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Figure 4.10.  Two time courses from I106A-F132A-H257W-catalyzed hydrolysis of the 
racemic GB analog.  The first (A) is with 0.0045 µg of protein, and the second (B) is with 
0.45 µg of protein.  By comparing the single exponential equations (red), the difference 
between the two phases is 505.   
    
 
              133
 
Time (min)
0 2 4 6 8 10 12 14
[F
-]
 
0
10
20
30
40
50
60
70
80
 
 
 
 
 
 
 
Figure 4.11.  The non-enzymatic hydrolysis of 0.5 mM GB at pH 7.72 at 25 °C.  The graph is 
expressed as concentration of fluorine in µM (y-axis) versus time in minutes (x-axis).  The 
rate constant for hydrolysis was 0.183 min-1 and the amplitude was 55.4, as determined by 
the single exponential fit to the plot. 
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Figure 4.12.  Wild type catalyzed hydrolysis of 0.5 mM GB at pH 7.72 at 25 °C.  The graph 
is expressed as concentration of fluorine in µM (y-axis) versus time in minutes (x-axis).  The 
rate constant for hydrolysis was 0.484 min-1 and the amplitude was 513, as determined by the 
single exponential fit to the plot. 
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Figure 4.13.  G60A catalyzed hydrolysis of 0.5 mM GB at pH 7.72 at 25 °C.  The graph is  
expressed as concentration of fluorine in µM (y-axis) versus time in minutes (x-axis).  The 
rate constant for hydrolysis was 0.412 min-1 and the amplitude was 503, as determined by the 
single exponential fit to the plot. 
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Figure 4.14.  I106A-H257Y catalyzed hydrolysis of 0.5 mM GB at pH 7.72 at 25 °C.  The 
graph is expressed as concentration of fluorine in µM (y-axis) versus time in minutes (x-
axis).  The rate constant for hydrolysis was 0.772 min-1 and the amplitude was 501, as 
determined by the single exponential fit to the plot. 
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Figure 4.15.  I106A-H257Y-S308A catalyzed hydrolysis of 0.5 mM GB at pH 7.72 at  
25 °C.  The graph is expressed as concentration of fluorine in µM (y-axis) versus time in 
minutes (x-axis).  The rate constant for hydrolysis was 0.451 min-1 and the amplitude was 
409, as determined by the single exponential fit to the plot.  The rate constants for hydrolysis 
were calculated from a double exponential fit as 0.954 min-1 and 0.029 min-1, and the 
amplitudes were 322 and 542.  
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Figure 4.16.  I106A-F132A-H257Y catalyzed hydrolysis of 0.5 mM GB at pH 7.72 at  
25 °C.  The graph is expressed as concentration of fluorine in µM (y-axis) versus time in 
minutes (x-axis).  The rate constant for hydrolysis was 0.0.472 min-1 and the amplitude was 
398, as determined by the single exponential fit to the plot.  The rate constants for hydrolysis 
were calculated from a double exponential fit as 1.16 min-1 and 0.053 min-1, and the 
amplitudes were 309 and 366.  
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Double enzyme plots were constructed by adding enzymes pair wise into 0.5 mM 
racemic GB solution.  In each case, the first enzyme was added at time zero.  After one 
minute of hydrolysis, the second enzyme was added into the cuvette.  The arrow in graphs A 
and B of Figure 4.17 denote the time of addition of the second enzyme.  The detection of 
hydrolysis was measured by the release of fluorine over time.   
In Figure 4.17A, I106A-F132A-H257Y was the first enzyme added.  The addition of 
I106A-H257Y-S308A as the second enzyme is shown in with an orange line, and it appeared 
to behave in the same way as the addition of I106A-F132A-H257Y as the second enzyme, 
which is marked by the blue line.  In contrast, there was a marked increase in fluorine when 
wild type protein was added as the second enzyme, which is illustrated by the red line in the 
graph.  A similar situation is seen in Figure 4.17B, in which I106A-H257Y-S308A was used 
as the first enzyme.  Both triple mutants behaved in the same manner, and a sharp increase in 
fluorine was seen with the addition of the wild type enzyme.   
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Figure 4.17.  The double enzyme plot of GB hydrolysis.  The triple mutant, I106A-F132A-
H257Y is the first enzyme added in the first plot (A), and I106A-H257Y-S308A is the first 
enzyme added in the second plot (B). 
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Discussion 
Libraries of PTE Mutants 
Most of the improvements for GB analog hydrolysis were seen with the Arg and Gly 
containing mutants isolated from the H254X-H257X library.  Almost all of the mutants 
identified as having increased activity for the Sp GB analog hydrolysis were of that 
description, as seen in Figure 4.8.  All of the mutants that appeared at least 2 times faster than 
the wild type from the crude culture screens did in fact have higher kinetic constants for the 
Sp GB analog isomer.  However, the ability to distinguish the level of enhancement was not 
accurately obtained from the screens.  For example, the H257R mutant appeared to be over 5 
times faster than the wild type as determined from the screening assays.  Upon purification, 
the mutant was 3 faster for Sp analog hydrolysis.  Conversely, the H254G-H257W mutant 
appeared to be only 3.5 times faster than the wild type, but after purification, the mutant was 
7.6 times faster than the wild type.     
The mutants from the H254X-H257X library within L303T proved to be less efficient 
at GB analog hydrolysis.  In fact, it appeared that fewer number of mutations within the 
His254-His257 region were beneficial.  The highest catalytic efficiencies for Sp isomer 
hydrolysis were reported for single mutants, or for mutants containing a single mutation 
within the large subsite.  As observed with the triple mutant I106A-F132A-H257W, the 
catalytic efficiency for Sp isomer hydrolysis was 1.1 x 107 M- 1s-1, exceeding wild type and 
other mutants.  Other single mutations such as H254A, H257Y, and H254R were also quite 
efficient, having catalytic efficiencies on the order of 106 M-1 s-1.  
Although there was very little improvement for GB analog hydrolysis with mutants 
obtained from the double substitution library in L303T, the stereoselective preference was 
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successfully reversed in comparison to the preference elicited by wild type protein.  Almost 
all of the mutants obtained from both H254X-H257X libraries were shown to preferentially 
hydrolyze the Sp isomer faster than the Rp isomer.  These results indicate that reversal of 
stereoselectivity was successfully achieved through directed evolution experiments with 
PTE. 
 
Kinetic Data Comparison   
Because the Rp isomer of the GB analog corresponds to the non-toxic isomer of GB, 
directed evolution experiments were only focused on improvements for Sp isomer hydrolysis.  
With the exception of the H254Q-H257F mutant, there were no improvements in Rp isomer 
hydrolysis within the H254X-H257X library.   The catalytic efficiency of Rp isomer 
hydrolysis was 1.2 times faster for H254Q-H257F in comparison to the wild type.   
Among the 17 samples tested, S308A had the highest turnover rate for Rp isomer 
hydrolysis, which was approximately 3 times faster than wild-type PTE.  The mutant, G60A, 
had the highest catalytic efficiency for the hydrolysis of the Rp GB analog.  It was 1000-
times higher than the lowest catalytic efficiency, which was reported for H254R-H257A-
L303T.  Almost all of the mutants with one or more mutations in the large subsite were much 
slower than the wild type for Rp isomer hydrolysis.  
Most of the improvements made for GB analog hydrolysis were seen with the 
improvement of rates for Sp isomer hydrolysis.  Enhancement of Sp isomer hydrolysis is 
crucial for detoxification of GB because the Sp isomer corresponds to the toxic isomer.   
Contrary to the results with the Rp isomer, many improvements were seen for Sp 
isomer hydrolysis with mutants containing only one mutation in the large subsite.  Half of 
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the mutants listed in Table 4.2 had a turnover rate that was higher than the wild type.  The 
mutant, I106A-S308A-H257Y, had the highest turnover rate for Sp isomer hydrolysis, which 
was almost a 25-fold enhancement in comparison to the wild type.  The highest catalytic 
efficiency for Sp isomer hydrolysis was reported as 1.1x107 M-1 s-1, and was equal to the 
highest catalytic efficiency for the complementary Rp isomer, as seen in Figure 4.2.   In fact, 
75% of the mutants exhibited enhanced catalytic efficiency for the hydrolysis of the Sp GB p-
NP isomer.   
 
Stereoselectivity Expressed as a Ratio  
There was a good correlation between the ratio of stereoselectivity obtained from 
both the kinetic parameters and from the time course with the GB analog racemate.  In 
general, the ratios differed from 1- to 2-times each other, and reflected comparable degrees of 
stereoselectivity.  For example, both H254R-L303T and H254R-H257A exhibited a low ratio 
between the catalytic efficiencies for each isomer.  Each protein had equal preference for the 
individual isomers as expressed in terms of kcat/Km, and a similar ratio of rates of hydrolysis 
within the racemic mixture.  The difference in rates of hydrolysis within the racemic mixture 
was 1-fold for the H254R-L303T, and for H254R-H257A it was 4-fold different. 
Even large ratios were distinguishable within the time course.  As an example, 
I106A-F132A-H257W preferentially hydrolyzed the Sp isomer in favor of the Rp isomer 367 
times faster, as determined by comparison of catalytic efficiencies.  A high degree of 
stereoselectivity was also reflected from the time course.  There was a 505-fold difference 
between rates of hydrolysis for the individual isomers within the racemic mixture.   
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Figures 4.12 to 4.16 were constructed from data with live nerve agent.  The 
concentration of GB used was kept low at 0.5 mM, to eliminate the effects of racemization.  
The data suggested varying degrees of stereoselectivity for different mutants of PTE, which 
was assumed after observing similar results with the GB analog.  Both triple mutants I106A-
F132A-H257Y and I106A-H257Y-S308A displayed a greater degree of stereoselectivity for 
hydrolysis of the individual isomers, when compared to the wild type (Figures 4.15, 4.16, 
and 4.12).  The differential rates of hydrolysis were visibly detected when compared to the 
wild type in Figure 4.12 and other mutant proteins in Figures 4.13 to 4.16.  By fitting the data 
to double exponential curves, it was determined that each triple mutant preferentially 
hydrolyzed one isomer 24-times faster than the other.  The ratio of 24, obtained from the 
rates of hydrolysis with live nerve agent, was similar to the ratio of 30, determined from the 
comparison of catalytic efficiencies between the individual pure isomers for I106A-F132A-
H257Y.   
In comparison, there was more variation between data with the live nerve agent and 
the analog for I106A-H257Y-S308A.  The ratio obtained from the kinetic data for the 
individual isomers was almost 5-times smaller than what was observed with live nerve agent.  
The situation was reversed with the wild type protein in that the difference of 4-fold, 
observed with the live agent was smaller than the difference of 20-fold, calculated from 
kinetic data.   
Pair wise additions of each of the triple mutants confirmed the stereoselectivity 
observed in Figure 4.17.  It appeared that both I106A-F132A-H257Y and I106A-H257Y-
S308A shared the same order of preference, as well as degree of stereoselectivity.  In 
contrast, the wild type preference was complementary to that of the triple mutants.  When 
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wild type was added, there was a sharp increase in fluorine detected.  This would perhaps 
indicate that the order of preference has been reversed by the mutants, and would also 
correspond to similar results with the GB analog.   
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CHAPTER V 
ORGANOPHOSPHATE NERVE AGENT ANALOG TOXICITY 
IN HYDRA ATTENUATA 
 
Introduction 
  Organophosphates have been utilized in various applications since their initial 
discovery in the early 19th century (Furtado and Chan, 2001).  Their most noted employment 
is usage as agricultural insecticides and chemical warfare agents.  Organophosphates were 
introduced as pesticides after World War II and subsequently incorporated into common 
agricultural practices ever since (Furtado and Chan, 2001).  It is estimated that approximately 
200 different organophosphate insecticides are currently used commercially worldwide 
(Klaassen, 1996).  The accumulation of these pollutants has raised environmental concerns 
due to the inherent toxicity of these compounds (US EPA, 2001).  In general, the mechanism 
of toxicity involves the inhibition of enzyme activities and the release of neurotransmitters 
(Klaassen, 1996).  Acute toxicity results primarily from the inactivation of the enzyme 
acetylcholine esterase (AChE).  However, other direct targets of organophosphate 
intoxication include the muscarinic and nicotinic acetylcholine receptors.  Symptomatic 
manifestations of organophosphate intoxication leading to death include pinpoint pupils, 
breathing difficulties, coma, and convulsions.  While the mechanism of toxicity is believed to 
be similar in all species, the chemical dosage directs the intensity of the response (Klaassen, 
1996)(Ecobichon and Joy, 1994).   
From studies on acute toxicity, LD50 values of organophosphates for humans have 
been estimated based on studies using mammals with a variety of chemical warfare agents 
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(Committee on Toxicology, 1997).  However, most of these studies were conducted between 
1940 and 1980, and almost all of these measurements were focused on controlled, acute 
exposures (Reutter, 1999).  The acquisition of new toxicity data is hampered by multiple 
regulations and government restrictions.  Some of these limitations involve animal sample 
size and the enormous expense associated with such studies.  In this investigation, the 
toxicities for chiral and achiral analogs of GB, GD, and VX were evaluated using Hydra 
attenuata as the model organism.     
Hydra attenuata is a common freshwater Cnidarian found in slow-moving waters  
(Karntanut and Pascoe, 2000).  Cnidarians are true metazoa with only two body layers; an 
outer epidermis and the inner gastrodermis.  As diploblasts, all of the cells are in close 
proximity to the aqueous medium and the immediate environment.  This particular feature 
enables Hydra to be very sensitive and susceptible to minute amounts of environmental 
toxicants.  In addition to sensitivity, the Hydra bioassay is remarkably reproducible because 
of asexual reproduction, yielding clones of individual organisms.  The cost and overall 
simplicity of this bioassay has contributed to an increase in the number of recent studies 
using Hydra in acute and chronic toxicity tests of water-soluble compounds (Ronco et al., 
2002)(Diaz-Baez, 2002).  Previous studies have exploited the use of the Hydra bioassay to 
assess the toxicity of various compounds including chlorinated phenols (Mayura, 1991), 
heavy metals (Karntanut and Pascoe, 2000), and estrogenic compounds (Pascoe et al., 2002).  
An investigation involving the invertebrate organism, Daphnia magna, has also shown a 
significant correlation with established rat oral LD50 values (Guilhermino et al., 2000).  
Therefore, this system shows great potential as an alternative means to animal testing in pre-
screening trials for the prediction of toxicity of specific organophosphate compounds.  
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Structure-activity relationships were established for the toxic properties using a series 
of chiral and achiral organophosphate analogs of the nerve agents GB, GD and VX.  The 
toxicity of each organophosphate nerve agent was quantitatively assessed by determining the 
minimal effective concentration (MEC) in Hydra after 92 hours.  The conclusions of this 
investigation correlate well with organophosphate toxicity studies previously described by 
Singh (Singh, 2001) and Makhaeva et al. (Makhaeva et al., 1998).  Based on the data from 
this investigation, there is significant potential for the application of this bio-assay in the 
detection of organophosphate chemical warfare agents, in addition to the prediction of 
toxicity for structurally similar organophosphate compounds. 
 
Materials and Methods 
Hydra attenuata   
Hydra attenuata were cultured from organisms that were received as a gift from  
E. Marshall Johnson, Jefferson Medical College (Philadelphia, PA).  Cultures of Hydra were 
maintained in shallow bowls of culture solution, and stored at 18 ºC.  The culture solution 
contained 1.0 mM calcium chloride, 0.45 mM TES (N-tris[hydroxymethyl]methyl-2-
aminoethane sulfonic acid) buffer, and 0.012 mM ethylenediamine tetracetic acid (EDTA), 
pH 7.0.  Deionized water was used throughout all of the maintenance and assay solutions.   
 
Artemia saliva 
Axenic nauplii of brine shrimp (Artemia saliva) were prepared on a daily basis, 
beginning three days before each bioassay was conducted.  The procedure and conditions for 
incubation were adapted from Lenhoff (Lenhoff, 1983).  After the nauplii were hatched in 
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1% (w/v) NaCl solution, they were treated with iodine (40 ppm) for 15 minutes and 
subsequently washed with deionized water.  The axenic nauplii were fed to the Hydra once a 
day for a period of 30 minutes.  After feeding, the debris from the feeding was removed by 
thorough rinsing of the Hydra with culture solution.  Food was withheld beginning twenty-
four hours before initiating the bioassay and throughout the testing period.   
 
Assay Procedures   
Procedures for this study were modified from those described by Johnson et al. 
(Johnson et al., 1982).   Only adult Hydra attenuata were used in the bioassays and each test 
was run in triplicate.  For each concentration of the tested compounds, 4 mL of culture media 
was placed in a small petri dish.  The control dish consisted of culture media alone.  All of 
the test dishes were incubated at 18 ºC throughout the assay.  Adult Hydra were observed for 
symptoms of toxic response at 0, 4, 20, 28, 44, 68, and 92 hours.   
The minimal effective concentration (MEC) at 92 hours was determined for each 
compound tested through a series of assays, consisting of three phases.  The first phase 
involved exposing adult Hydra to whole log concentrations of each compound, to determine 
the range of toxicity apparent within 92 hours.  The “tulip” stage was defined as the toxic 
endpoint of each assay.  The lowest concentration of the test compound resulting in the toxic 
endpoint (e.g. MEC) was carried forward to the second phase of testing.  In phase II of 
testing, the highest and lowest concentrations of the compound were within one log unit of 
one another.  The MEC from the second phase of testing was used as the highest 
concentration in the phase III testing.  The results from the phase III test were used to 
confirm those of the previous assays.   
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Chemicals and Reagents  
All buffer reagents were purchased from Sigma Chemical Co.  Aroclor 1254-induced 
male rat liver, post mitochondrial supernatant (S-9) was purchased from Molecular 
Toxicology (Boone, NC) and used as the microsomal activation package (MAP).  Synthesis 
of the racemic GB analog (IV) and the racemic GD analog (V), along with the chemo-
enzymatic preparation of the chiral analogs were prepared as described in Li et al. (Li et al., 
2001).   The VX analogs, ecothiophate iodide (VI), diethyl VX (VII), and tetriso (VIII), and 
were synthesized by modifications of procedures described in the literature (Ghosh, 
1957)(Hoskin et al., 1969).  All of these compounds are toxic and should be used with the 
appropriate safeguards.  
 
Structure Activity Analysis 
           A model for each of the organophosphate compounds was made using  
ISIS/DRAW.  The resulting files were imported into HyperChem Release 7 (Hyper Cube, 
Inc.), and various calculations were carried out.  Properties, such as the octanol-water 
partition coefficient and polarizability, were obtained for each of the compounds tested.  
HyperChem calculations were made by a grid method assessment of van der Waals and 
solvent-accessible surfaces (Hasel et al., 1988).  Determination of the octanol/water partition 
coefficients was based on implementation of an atom fragment method as described by 
Ghose et al. (Ghose et al, 1988).  Polarizability information was deduced using an atom-
based method as described by Miller (Miller, 1990).  Geometry optimization data and 
molecular dynamics calculations were also determined after the structures of the compounds 
were modeled in Cerius2 from Accelrys on a Silicon Graphics workstation.   
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Results 
Chemical Compounds 
A total of 10 different compounds were synthesized and analyzed for their 
toxicological properties using Hydra as the test system.  Methyl isopropyl p-nitrophenyl 
phosphate (II) was utilized as a racemic mixture, while the sarin analog (IV) was prepared as 
individual enantiomers.  The soman analog (V) was used as a mixture of 4 diastereomers, a 
mixture of the two possible Sp isomers, and as the single SpSc enantiomer.  The three analogs 
of VX (VI, VII and VIII) are achiral.  The structures of these compounds are presented in 
Scheme 1.   
 
 
Scheme 1.  The test substrates used in the Hydra Bioassay; p-nitrophenol (I), methyl 
isopropyl p-nitrophenyl phosphate (II), paraoxon (III), the GB analog, methyl isopropyl p-
nitrophenyl phosphonate, methyl pinacolyl p-nitrophenyl phsophonate (IV), ecothiophate 
(V), diethyl VX (VII), and tetriso (VIII). 
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Hydra Bioassay 
Hydra were used to assess the toxicological properties of selected organophosphate 
nerve agents.  In these tests, the Hydra were observed to undergo a series of morphological 
changes as a function of time and these physical changes are illustrated in Figure 5.1.  The 
tentacles first begin to be “clubbed” at the end (Figure 5.1B) and then shorten in length 
(Figure 5.1C).  The Hydra continue to shrink to a “tulip” stage (Figure 5.1D) and then 
eventually disintegrate (Figure 5.1E).  The “tulip” stage is defined as the toxic endpoint.  The 
minimum effective concentration was determined for each compound through a series of 
three tests.  In the first test, the compound was assayed in increments of whole log 
concentrations.  During the first stage of testing, the concentration at which the Hydra 
reached the toxic endpoint within 92 hours was used as the upper limit in the second phase of 
the assay.  For example, the toxicity of paraoxon (III) on Hydra was first examined with a 
range from 2.5 x 10-4 to 2.5 x 102 mg/L.  From this initial assessment, the toxicity after 92 
hours occurred from an exposure to paraoxon that was within the range from 2.5 to 25 mg/L.  
Representative data are presented in Figure 5.2.  The second and third tests (data not shown) 
confirmed that the MEC92h was 25 mg/L.  Throughout each phase of testing, the culture 
solution was used in the absence of added nerve agent as a negative control to ensure the 
integrity of the Hydra throughout the assay.  The MEC92h values for the remaining 9 
compounds were determined in exactly the same manner and the final values are summarized 
in Table 5.1.     
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Table 5.1.  The MEC92h (mg/L) for each of the compounds administered are listed with the 
corresponding calculated log partition coefficient. 
 
 
 
Compound 
MEC92h 
(mg/L) 
log 
partition 
coefficient 
[octanol/water] 
I 9.4 x 101 -2.2 
(RP/SP)-II 6.0 x 101 -0.92 
III 2.5 x 101 -0.99 
(RP)-IV 1.0 x 102  
(RP/SP)-IV 2.0 x 10-2 -1.5 
(SP)-IV 1.3 x 10-2  
(RPRC/RPSC/SPRC/SPSC)-V 2.5 x 10-4 -0.12 
(SPRC/SPSC)-V 2.0 x 10-4  
(SPSC)-V 8.0 x 10-5  
VI 1.0 x 10-4 2.0 
VII 3.0 x 10-6 3.1 
VIII 3.0 x 10-6 3.9 
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A  B  C  D  E 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1.  The physical stages of adult Hydra attenuata.  The stages involve the following: 
(A) normal state; (B) clubbed tentacles; (C) shortened tentacles; and (D) the tulip stage, also 
defined as the toxic endpoint of the bioassay (E). 
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Figure 5.2.  The time course for the toxic effect of various concentrations of paraoxon on 
Hydra attenuata.  The symbols represent the morphologic changes as defined in Figure 5.1.  
Additional details are provided in the text. 
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Of the ten compounds tested for toxicity with Hydra, two of the VX analogs (VII and 
VIII) were the most toxic.  The two Sp isomers of the GD analog (V) were approximately two 
orders of magnitude less toxic than the two most toxic analogs for VX.  The most toxic 
enantiomer of the analog for GB (Sp-IV) was approximately 2 orders of magnitude less toxic 
than the most toxic analog for GD (SpSc-V).  In contrast the Rp enantiomer of IV was 
approximately 4 orders of magnitude less toxic the corresponding Sp enantiomer.  Overall, 
the compounds tested varied in toxicity by approximately 8 orders of magnitude.  This order 
of toxic properties by the various analogs of GB, GD, and VX mirrors the toxicity of the 
nerve agents GB, GD, and VX (Scheme 2).  Shown in Figure 5.3 is a plot of the MEC92h 
values measured in this study for organophosphate nerve agent analogs IV, V, and VII versus 
the reference dosage (mg/kg/day) for GB (2 x 10-5), GD (4 x 10-6), and VX (6 x 10-7), which 
estimates the daily exposure level that can be tolerated without harmful effects during a 
lifetime (Subcommittee on Chronic Reference Doses, 2000).  The relative toxicity for the 
analogs is consistent with the relative toxicity displayed by the CW agents themselves. 
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Figure 5.3.  Comparison of the MEC92h (mg/L) for the organophosphate nerve agent analogs 
IV, V, and VII determined in this investigation versus the reference dose (mg/kg/day) for the 
chemical warfare agents sarin (GB), soman (GD) and VX. 
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Scheme 2.  The stereoisomers of sarin (GB), soman (GD), and VX. 
 
  
 
The test compounds were modeled in ISIS/DRAW, and the resulting files were 
analyzed using HyperChem Release 7 (Hyper Cube, Inc.).  Molecular dynamics calculations 
including geometry optimization energy, volume, and surface area were obtained for each 
compound, in addition to the polarizability and the partition coefficient for a mixture of 1-
octanol and water (Figures 5.6 and 5.7).  The lowest and highest geometry optimization 
energies were calculated for each of the compounds, as shown in Figure 5.4.  The physical 
properties of volume, surface area, and mass for each of the compounds was also determined, 
as illustrated in Figure 5.5.  Of these molecular properties the partition coefficient in 
octanol/water gave the best correlation relative to the MEC92h values determined here, as 
illustrated in Figure 5.8.  
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Figure 5.4.  The lowest (blue) and highest energy (red) of the compounds as determined by 
the Boltzmann Conformer Search Method for each of the test compounds.   
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Figure 5.5.  The physical properties of volume, surface area, and mass for each of the test 
compounds. 
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Figure 5.6.  The polarizability for each of the compounds tested is expressed in Å3.   
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Figure 5.7.  The molecular hydrophobicity is expressed as log P, the partitition coefficient of 
octanol:water, for each test compound. 
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Figure 5.8.  Correlation between the log of the partition coefficient for a mixture of 
octanol/water and the MEC92h for the compounds assayed in this investigation.  The solid 
line through the data is for comparison purposes only. 
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Discussion 
Hydra Bioassays 
Exposure to each organophosphate compound tested led to toxicity in Hydra.  In 
terms of the MEC within 92 hours of exposure, the leaving group product, para-nitrophenol 
(I) was among the least toxic compound whereas two of the VX analogs, diethyl VX (VII) 
and tetriso (VIII), were the most toxic (Table 5.1).  The toxicity elicited from p-nitrophenol 
was significantly lower than that of the various GB and GD analogs tested and thus it can be 
concluded that the lethality from exposure to these organophosphates was not due to the 
presence or accumulation of the leaving group product.  However, the GB analog (II) and 
paraoxon (III) induced lethality only at relatively high concentrations.  From this observation, 
it can be concluded that the organophosphate triesters have less of an inhibitory effect than 
the organophosphonate diesters on AChE in vivo, and are thus tolerated at higher 
concentrations.  In contrast, organophosphonate diesters, containing a P-CH3 substituent, 
cause significantly greater toxicity, which is supported by the data from exposure to the GB 
(IV) and GD (V) analogs.  In comparing the two GB analogs (II and IV), the racemic 
phosphonate GB analog (IV) was significantly more toxic than that of the corresponding 
phosphate analog of GB (II), yielding a 3000-fold difference in MEC92h.   
A notable effect on toxicity was observed on the stereochemistry at the phosphorus 
center for the two isomers of the GB analog (IV), and the stereoisomers of the GD analog 
(V).  Exposure to the Sp isomer of IV led to a 7,600-fold greater toxicity than that observed 
for the Rp isomer.  The differential toxicity has also been noted in studies with rodents 
exposed to individual nerve agent isomers of GB (Spruit et al., 2000).  The rate constant for 
the inactivation of AChE for the Sp isomer of GB was shown to be 5000-fold greater than 
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that of the Rp isomer (Benschop and De Jong, 1988). The difference in the rate of 
inactivation of AChE is even greater between the most toxic SpSc isomer of GD and the 
relatively non-toxic RpRc isomer of GD (Benschop and De Jong, 1988). 
The MEC for the GB analog (IV) is 100-fold greater than for the GD analog (V).  
From the literature it has been noted that GD is more toxic than GB, and that a differential 
toxicity occurs among the isomers of both nerve agents (Benschop and De Jong, 1988).  The 
MEC in Hydra revealed that the most toxic isomer within the racemic GD analog (V) is of 
the SP configuration.  The MEC of the isolated SpSc isomer is ~3 times lower than that of the 
racemic mixture.  The results from this study are similar to those of Benschop et al., which 
indicate that the most toxic isomer in mouse studies is the SpSc isomer of GD (Benschop and 
De Jong, 1988).  Experimental evidence also indicates that the SpSc isomer of GD is the most 
reactive with human AChE, and that the chirality at the phosphorus center is the most 
important element in determining the stereoselective toxicity (Ordentlich et al., 1999). 
The compounds with the lowest values for MEC were the VX analogs, VI, VII, and 
VIII (Table 5.1).  While the MEC for VI was only about half of that for the GD analog (V), 
the toxicity elicited from VII and VIII was ~100-fold greater than that for V.  Both of these 
VX analogs caused lethality in Hydra at a concentration that was ~7 orders of magnitude less 
than that of paraoxon.  However, the toxicity of diethyl VX (VII) was reduced by 10,000-fold 
(data not shown) in the presence of MAP, consisting of enzymes present within the S9 
fraction from Aroclor 1254-induced male rats.  From these data, it appears that the various 
enzymes present in MAP aid in the detoxification of diethyl VX, and perhaps structurally 
similar compounds as well.  Overall, the VX analogs were more toxic than the GD analogs, 
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which in turn were more toxic than the GB analogs, as expected from the known order of 
toxicity (Munro, 1994).   
 
Molecular Modeling 
All of the compounds used in the bioassays were modeled with HyperChem.  In many 
studies, it has been reported that polarizability and hydrophobicity are significant factors in 
determining toxicity and drug reactivity (Hansch and Kurup, 2003)(Makhaeva et al., 1998).  
Polarizability for each compound was determined by van der waals (dispersion) forces, and 
has units of volume (Å3).  In order to calculate the electric dipole polarizability (α) in units of 
e2ao2Eh-1, energy in terms of hartrees (Eh = 4.3597E-18 J) would have to be calculated.   
However from the bar graph in Figure 5.6 it is apparent that increased polarity is directly 
related to increased toxicity.   
Molecular hydrophobicity was determined for each compound in terms of the 
partition coefficient for an octanol/water mixture.  The leaving group for four of the 
compounds tested here, p-nitrophenol, was the most water soluble while tetriso was the most 
soluble in octanol.  The most hydrophobic compounds exhibited greater toxicity as illustrated 
in Figures 5.7 and 5.8.  These findings are in agreement with the hypothesis that hydrophobic 
organophosphorus compounds quickly enter the nervous system, and become readily 
available to attack multiple targets involved in organophosphate induced toxicity (Klaassen, 
1996).  It has been previously established that there is a good correlation between the 
partition coefficient for organophosphate compounds and NTE inhibition (Singh, 2001), and 
that an increase in OPIDN is observed as the hydrophobicity of a compound is increased 
(Makhaeva et al., 1998). 
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Potential Applications  
The Hydra bioassay may be incorporated into an array of other applications.  The 
ability of this organism to detect ppm to ppt levels of organophosphate nerve agents enhances 
the degree of sensitivity demanded by biosensors.  In addition, the cost, efficiency, and ease 
of this assay permit it to be run multiple times in a variety of formats. Because Hydra 
attenuata are sensitive to the organophosphates and organophosphonates tested here, it is 
assumed that the organism will be sensitive to related compounds.  The bioassay used here 
could be applied as a pre-screening tool in determining the relative toxicity of related 
organophosphorus nerve agents, as well as individual stereoisomers, that have yet to be 
screened for toxicity. 
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CHAPTER VI 
SUMMARY AND CONCLUSIONS 
 
The stereoselectivity of sarin (GB) and soman (GD) analog hydrolysis is an important 
issue for assessing the use of PTE as an effective means of decontamination and 
detoxification of chemical warfare agents.  It has been an underlying theme for the direction 
of experiments described throughout this dissertation.  From Chapter II, it was established 
that wild type exerts stereoselectivity in the direction of Rp over Sp for both the GB and GD 
analogs.  This is consistent with results from investigations probing structural determinants 
of substrate specificity (Chen-Goodspeed et al., 2001a,b).  In such studies, it was concluded 
that wild type consistently preferred the Sp enantiomer over the corresponding Rp enantiomer 
from a variety of related organophosphate substrates, with factors ranging from 1-90 (Chen-
Goodspeed et al., 2001a).  With the Sp enantiomer, the larger substituent of the substrate fits 
in the large subsite, while the smaller substituent fits in the small subsite.  The Sp enantiomer 
of phosphate substrates used in those studies corresponds to the Rp enantiomer(s) of the 
phosphonate substrates used throughout the experiments described in this dissertation.   
Subtle modifications to the enzyme yielded variants with complementary 
stereoselectivities, as seen with G60A and the triple mutant I106A-F132A-H257Y.  This 
illustrates the capabilities of effectively tailoring PTE to hydrolyze individual isomers of a 
substrate.  A subtle modification in the small subsite yielded a mutant with enhanced activity 
for the Rp isomer, while maintaining the same stereoselectivity as wild type as seen with 
G60A.  However, the Rp isomer for both GB and GD is not biologically relevant in terms of 
eliciting toxicity.  It is believed that the Rp enantiomer serves as a substrate for other 
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enzymes similar to AChE, such as butylrylcholinesterase (Langenberg et al., 1998).  The Sp 
isomer of GB, and the SpSc and SpRc isomers of GD are responsible for toxicity, as indicated 
by results from both toxicity and toxicodynamics studies (Benschop and De Jong, 
1988)(Spruit et al., 2000).     
Modifications in the small subsite, large subsite, and leaving group pocket resulted in 
a triple mutant that was able to reverse the preference observed with wild type, such that the 
Sp isomer was preferentially hydrolyzed over the Rp isomer for both the GB and GD analogs.  
There was a substantial enhancement for Sp isomer(s) hydrolysis, as there was a 50-fold 
increase with the kcat and a 75-fold increase with the kcat/Km for hydrolysis of the Sp isomers 
of the GD analog.   
In Chapter III, directed evolutions studies of PTE combined with screen assays aided 
in the identification of other mutants with enhanced activity for GD analog hydrolysis.  In 
particular, substitutions within the large subsite and leaving group region proved to be the 
most beneficial for hydrolysis of the toxic Sp isomers of the analog.  From the single 
substitution libraries, the mutants Y309F and Y309W showed a 53-fold and 88-fold 
enhancement for hydrolysis of the most toxic SpSc isomer.  Aromatic amino acid substitution 
at position 257 also proved to be beneficial for SpRc/SpSc isomers hydrolysis, as observed 
with the identification of H257Y and H257W mutants.  The H257Y mutation had the greatest 
enhancement for hydrolysis of the SpRc/SpSc isomers and the individual SpSc isomer of all the 
single mutations isolated.  There was a 57-fold enhancement for the hydrolysis of the Sp pair 
of isomers, with a kcat/Km of 5.4 x 103 M-1 s-1, and a 88-fold enhancement for the hydrolysis 
of the individual SpSc isomer, with a kcat/Km of 1.4 x 103 M-1 s-1.   
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An even greater degree of enhancement was seen with mutants obtained from the 
double substitution libraries.  An overwhelmingly large population of enhanced mutants 
obtained from the screening of these libraries contained Arg and Gly mutations at position 
254, while Tyr at position 257 also proved to be a beneficial modification for the hydrolysis 
of the toxic isomers of the GD analog.  In addition, almost all of these mutants had reversed 
the order of stereoselectivity that was seen with wild type.  They had preference for the Sp 
isomer over the Rp isomer.  Among this description were H254G-H257R, H257Y-L303T, 
H254R-H257A-L303T, and H254R-H37S-L303T.   
The best mutant for SpRc and SpSc isomer hydrolysis was H257Y-L303T.  There was 
an 86- and 462-fold increase relative to wild type, respectively.  Preferential hydrolysis was 
in the order of the SpRc isomer, SpSc isomer, RpSc isomer, and RpRc isomer.  The triple 
mutant H254R-H257S-L303T also displayed a significant enhancement for hydrolysis of 
these isomers.  There was a 89-fold increase for hydrolysis of the SpRc isomer, and a 194-
fold increase for the hydrolysis of the SpSc isomer.  Comparable results were seen with a 
similar mutant, H254R-H257A-L303T.  For the respective isomers, there was a 34- and 150-
fold enhancement relative to wild type. There was a 106-fold enhancement for hydrolysis of 
the SpSc isomer with the H254G-H257R mutant, and the screening of the same library led to 
the isolation of H257Y, which was initially obtained from the H257X single substitution 
library.  The reappearance of this single mutation confirmed previous results. 
The double substitution library was also screened for activity with the isomers of the 
GB analog.  Many of these mutants had preference for the Sp isomer over the Rp isomer.  
However, there was a lesser degree of enhancement for hydrolysis of the GB analog.  There 
was a 9-fold increase for hydrolysis of the Sp isomer for the H257Y-L303T mutant, which 
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was among the highest for the mutants obtained from the double substitution libraries.  The 
H254G-H257W and H254G-H257R mutants had 8- and 5-fold increases for activity.  The 
mutant with the highest activity for Sp isomer hydrolysis was the triple mutant I106A-
F132A-H257W, and the mutant with the highest activity for Rp isomer hydrolysis was G60A.  
The kcat/Km for both was equal, with each being 1.1 x 107 M-1 s-1.  Both of these mutants 
were isolated by previous members of the Raushel group, and determined to have enhanced 
stereoselectivity for G60A and reversed stereoselectivity for the triple mutant (Chen-
Goodspeed et al., 2001a,b). 
In terms of stereoselectivity, many mutants obtained from the screen assays appeared 
to have reversed the order of preferential hydrolysis for both the GB and GD analogs.  To 
confirm what was observed with the analogs, two triple mutants were tested with GB at 
Edgewood Chemical Biological Center.  The I106A-F132A-H257Y and I106A-H257Y-
S308A mutants were assayed with 0.5 mM GB at pH 7.72.  With the later, there was a 33-
fold difference between the rate constants obtained from the double exponential fit of 
hydrolysis.  With the former, a 22-fold difference between the rate constants was observed.  
Assuming that the preference of both triple mutants is for the Sp isomer over the Rp isomer, 
as observed with comparable analogs, it is presumed that the Sp isomer of GB is hydrolyzed 
first, followed by the Rp isomer for these mutants.  If this were true, such an enzyme would 
be desired for use in the detoxification of live nerve agent because of its ability to 
preferentially hydrolyze and detoxify the toxic isomer.     
Prior to the work with the Hydra animal system, toxicity of the analog compounds 
was never established.  The Hydra bioassay proved to be a convenient and sensitive method 
of determining toxicity of the 8 compounds.  It was accurate enough to distinguish between 
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the isomers of the GB analog, as there was a 7600-fold difference between the minimal 
effective concentration (MEC92) of the Sp and Rp isomers.  The difference observed with the 
Hydra was comparable to what was observed with AChE inhibition by the respective 
isomers, which yielded a 5000-fold difference in terms of inhibition rate constant (Benschop 
and De Jong, 1988).  It was clear from the results that the Sp isomer was responsible for 
toxicity when the MEC92 values were compared to that of the Rp, as well as the racemic 
mixture. 
Also as expected, differential toxicity was observed between the SpSc isomer of the 
GD analog and the racemic mixture.  The difference was only 3-fold but it was clear from the 
MEC92 values that the SpRc/SpSc isomers were eliciting the toxicity within the racemic 
mixture.  As presumed, the toxicity of the GD analog was greater than that of the GB analog.  
From the assay, there was a 100-fold difference between the MEC92 values for each.  In turn, 
the GB analog was more toxic than the phosphate GB analog, paradoxes, and the p-nitro 
phenol compound.  The range of MEC92 values spanned 7 orders of magnitude, such that the 
greatest toxicity was seen with the VX analogs, specifically the diethyl VX and tetriso 
compounds.   
There was a distinct difference between the effects elicited by each compound tested, 
and as expected, the VX analogs were most toxic, followed by the GD analog, and the GB 
analog.  In all animals tested, VX has been shown to be the most toxic when administered 
subcutaneously (Hartmann, 2002), and in most cases, GD is more toxic than GB in terms of 
inhalational toxicity (Spruit et al., 2000).   Future use of this bioassay system with PTE could 
effectively demonstrate the ability of the enzyme to detoxify the nerve agents, GB, GD, and 
VX, as well as indicate the differential properties of individual variant proteins.  This would 
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eventually lead to the formulation of an enzyme cocktail designed to combat the individual 
isomers of each nerve agent. 
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